{"numRecords":"174","DataElementQueryResults":[{"publicId":"4253067","version":"1","preferredName":"Central Nervous System Disease Progression Location Type","preferredDefinition":"The response regarding the location of disease progression following treatment for their CNS disease.","longName":"4232093v1.0:4232128v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5872458-788A-CF5D-E040-BB89AD4336D6","latestVersionIndicator":"Yes","beginDate":"2014-03-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-03-26","modifiedBy":"COBARRUBIAK","dateModified":"2021-09-08","changeNote":"PBTC_ghd_03/26/14 released PBTC_WMS_070815","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4260918","version":"1","preferredName":"Central Nervous System Disease or Disorder Response CNS Disease or Disorder Response Status","preferredDefinition":"The part of the nervous system that consists of the brain, spinal cord, and meninges._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._Any act or phenomena, or behavior, constituting a reply or reaction of a living organism or its part to some foregoing stimulus or agent._A condition or state at a particular time.","longName":"4253105v1.0:4253136v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F600AD3A-AB7A-073E-E040-BB89AD431C87","latestVersionIndicator":"Yes","beginDate":"2014-04-01","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-04-01","modifiedBy":"SWEW","dateModified":"2015-03-18","changeNote":"PBTC_STD_ghd_04/01/14","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4267095","version":"2","preferredName":"Cyclin-Dependent Kinase Inhibitor Administered Indicator","preferredDefinition":"The yes/no response indicating whether or not a person has been previously treated with a CDK inhibitor.","longName":"CDK_IHBT_ADM_IND","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"339D5AD4-AE70-E936-E050-BB89AD437D6D","latestVersionIndicator":"Yes","beginDate":"2014-04-13","endDate":null,"createdBy":"SWEW","dateCreated":"2016-05-24","modifiedBy":"SWEW","dateModified":"2016-08-29","changeNote":"PBTC_WMS_041314 Versioned CDE from 1.0 to 2.0 by creating a human readable definition and modifying the long name and the short name of the CDE. wms 052416.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4267115","version":"2","preferredName":"Retinoblastoma-associated Protein Neoplasm Negative Finding Indicator","preferredDefinition":"The yes or no response indicating whether or not a person has a tumor with Rb1 negative result.","longName":"RB1_NEO_NEG_FNG_IND","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"395A4080-481B-085B-E050-BB89AD437033","latestVersionIndicator":"Yes","beginDate":"2014-04-13","endDate":null,"createdBy":"SWEW","dateCreated":"2016-08-05","modifiedBy":"SWEW","dateModified":"2016-08-29","changeNote":"PBTC_WMS_041314 8/5/16 wms - change of version to 2.0 with updated long name, short name and definition.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4270398","version":"1","preferredName":"Person Greater Body Surface Area Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"The yes/no/not applicable response regarding whether a patient has met the eligibility criteria for body surface area.","longName":"3243739v1.0:3506036v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F718FA7A-8A19-2896-E040-BB89AD436D18","latestVersionIndicator":"Yes","beginDate":"2014-04-15","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-04-15","modifiedBy":"SHUJIEH","dateModified":"2018-02-07","changeNote":"PBTC_ghd_04-15-14","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4271558","version":"1","preferredName":"Patient Performance Status Clinical Trial Eligibility Criteria Yes No Indicator","preferredDefinition":"A measure of how well a patient is able to perform ordinary tasks and carry out daily activities._Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol._The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"4271557v1.0:3506068v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F72035CB-6F6F-B99E-E040-BB89AD434E3C","latestVersionIndicator":"No","beginDate":"2014-04-15","endDate":null,"createdBy":"SWEW","dateCreated":"2014-04-15","modifiedBy":"HARTLEYG","dateModified":"2016-08-29","changeNote":"PBTC_WMS_041514","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4271558","version":"2","preferredName":"Patient Performance Status Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"The yes/no indicator response that describes the method used to assess the Karnofsky or Lansky performance status scale, representing the functional capabilities of a person.","longName":"PT_PERF_STAT_CTEC","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"339D5AD4-AD99-E936-E050-BB89AD437D6D","latestVersionIndicator":"Yes","beginDate":"2014-04-15","endDate":null,"createdBy":"SWEW","dateCreated":"2016-05-24","modifiedBy":"SHUJIEH","dateModified":"2020-08-04","changeNote":"PBTC_WMS_041514 Versioned CDE from 1.0 to 2.0 to create a human readable definition, revise the long name and short name of the CDE. wms 052416.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4271580","version":"2","preferredName":"Autologous Stem Cell Rescue Myeloablative Chemotherapy Administered Indicator","preferredDefinition":"The yes or no indicator of whether a person has previously treated with myeloablative Chemotherapy with Stem Cell Rescue.","longName":"ASCR_MYL_CT_ADM_IND","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"39AB437D-C291-5132-E050-BB89AD4333A6","latestVersionIndicator":"Yes","beginDate":"2014-04-15","endDate":null,"createdBy":"SWEW","dateCreated":"2016-08-09","modifiedBy":"SWEW","dateModified":"2016-08-29","changeNote":"PBTC_WMS_041514 8/9/16 wms - CDE was versioned to 2.0 to update the long name, definition and the short name.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4281091","version":"2","preferredName":"Patient Negative Pregnancy Test Indicator","preferredDefinition":"A yes/no/not applicable response indicating whether a patient has a negative pregnancy test result.","longName":"PT_NEG_PREG_TST_IND","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"39AA92F5-6242-CEA8-E050-BB89AD435F9E","latestVersionIndicator":"Yes","beginDate":"2014-04-24","endDate":null,"createdBy":"SWEW","dateCreated":"2016-08-09","modifiedBy":"SWEW","dateModified":"2016-08-29","changeNote":"PBTC_WMS_042414 Updated with Preferred Question 042616 slr 8/9/16 wms - CDE was versioned to update the long name, human readable definition and the friendly short name.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4287135","version":"1.1","preferredName":"Eye Examination Performed Date","preferredDefinition":"The date on which a test or an examination pertaining to the eyes was performed by an ophthalmologist or optometrist.","longName":"EYE_EX_PRFM_DT","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"395B4D15-7F1B-F1D5-E050-BB89AD435CDC","latestVersionIndicator":"Yes","beginDate":"2014-05-01","endDate":null,"createdBy":"SWEW","dateCreated":"2016-08-05","modifiedBy":"SOKKERL","dateModified":"2019-03-21","changeNote":"PBTC_WMS_050114 wms 8/5/16 - versioned CDE with an update of human readable definition and friendly short name.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4287507","version":"2","preferredName":"Correlative Study Specimen Collection Time","preferredDefinition":"The time at which the sample for pharmacokinetic or other correlative study was collected.","longName":"COR_ST_SPEC_COLL_TM","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"DRAFT MOD","registrationStatus":"Application","id":"F7947251-88C3-1DFD-E053-731AD00ADD32","latestVersionIndicator":"Yes","beginDate":"2014-05-01","endDate":null,"createdBy":"ZHWENDY","dateCreated":"2023-03-23","modifiedBy":"ZHWENDY","dateModified":"2023-03-23","changeNote":"PBTC_WMS_050114 8/5/16 wms - CDE version was updated to v1.1 with human readable definition and friendly short name.","administrativeNotes":"3/23/2023: versioned to replace the retired DEC. wz","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4287526","version":"2","preferredName":"Correlative Study Specimen Collection Date","preferredDefinition":"The date on which the sample for pharmacokinetic or other correlative study was collected.","longName":"COR_ST_SPEC_COLL_DT","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"DRAFT MOD","registrationStatus":"Application","id":"F7948FE6-2416-21BE-E053-731AD00AE0C1","latestVersionIndicator":"Yes","beginDate":"2014-05-01","endDate":null,"createdBy":"ZHWENDY","dateCreated":"2023-03-23","modifiedBy":"ZHWENDY","dateModified":"2023-03-23","changeNote":"PBTC_WMS_050114 8/5/16 wms - CDE was versioned to 1.1 with updated human readable definition and friendly short name.","administrativeNotes":"3/23/2023: versioned to replace the retired DEC. wz","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4287607","version":"2","preferredName":"Person Protocol Screen Indicator","preferredDefinition":"Evaluation or assessment of an individual's eligibility to enter a clinical trial.","longName":"2184689v1.0:3506036v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"32F98FE9-8990-860B-E050-BB89AD4304B6","latestVersionIndicator":"Yes","beginDate":"2014-05-01","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-05-16","modifiedBy":"TITARENKOI","dateModified":"2020-06-08","changeNote":"PBTC_WMS_050114; Versioned to create a human readable definition and revise the long name of the CDE 05.16.16 ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4287704","version":"1.1","preferredName":"Correlative Study Specimen Shipping Date","preferredDefinition":"The date on which the specimen for pharmacokinetic or other correlative study was transported from one location to another.","longName":"COR_ST_SPEC_SHIP_DT","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"37F24F23-0676-ADE8-E050-BB89AD432E95","latestVersionIndicator":"Yes","beginDate":"2014-05-01","endDate":null,"createdBy":"SWEW","dateCreated":"2016-07-18","modifiedBy":"LISU","dateModified":"2020-06-07","changeNote":"PBTC_WMS_050114 wms 07/18/16 - CDE was versioned to revise the definition and short name.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4289234","version":"2","preferredName":"Magnetic Resonance Imaging Vertebral Column Assessment Status","preferredDefinition":"The status of an imaging assessment of the spine/spinal cord utilizing the imaging technique that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide amazingly clear and detailed pictures of internal organs and tissues.","longName":"MRI_VC_ASSMT_STAT","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"33D9B30C-2BE0-B408-E050-BB89AD4325BD","latestVersionIndicator":"Yes","beginDate":"2014-05-02","endDate":null,"createdBy":"SWEW","dateCreated":"2016-05-27","modifiedBy":"RICHARDS","dateModified":"2020-04-02","changeNote":"PBTC_WMS_050214 wms 052716 - versioned CDE from v1 to v2 due to the versioning of DEC.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4289242","version":"2","preferredName":"Magnetic Resonance Imaging Vertebral Column Assessment Date","preferredDefinition":"The date on which the imaging assessment of the spine/spinal cord was done using the Magnetic Resonance Imaging technique.","longName":"MRI_SPN_ASMT_DT","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"39AA92F5-61F4-CEA8-E050-BB89AD435F9E","latestVersionIndicator":"Yes","beginDate":"2014-05-02","endDate":null,"createdBy":"SWEW","dateCreated":"2016-08-09","modifiedBy":"RICHARDS","dateModified":"2020-04-02","changeNote":"PBTC_WMS_050214 8/9/16 wms - CDE was versioned to 2.0 to simplify the long name, update the definition and the short name.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4289596","version":"2","preferredName":"Ommaya Reservoir Status Indicator","preferredDefinition":"The yes/no/na response related to whether or not a plastic, dome-shaped device is implanted under scalp for the delivery of drugs (e.g. chemotherapy) to the central nervous system.","longName":"OMYA_RES_STAT_IND","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"339E2F80-089D-89CB-E050-BB89AD4362D9","latestVersionIndicator":"Yes","beginDate":"2014-05-04","endDate":null,"createdBy":"SWEW","dateCreated":"2016-05-24","modifiedBy":"SWEW","dateModified":"2016-08-29","changeNote":"PBTC_WMS_050414 Versioned CDE from 1.0 to 2.0 by creating a human readable definition and modifying the long name and the short name of the CDE. wms 052416.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4289604","version":"2","preferredName":"Cerebrospinal Fluid Ventricular Collection Site","preferredDefinition":"The collection site for CSF within the ventricles of the brain.","longName":"CSF_COLL_ST","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3959B4E9-1E4A-09C5-E050-BB89AD430A7F","latestVersionIndicator":"Yes","beginDate":"2014-05-04","endDate":null,"createdBy":"SWEW","dateCreated":"2016-08-05","modifiedBy":"SWEW","dateModified":"2016-08-29","changeNote":"PBTC_WMS_050414 8/5/16 wms - changed version from 1.0 to 2.0 to simplify the long name, update the definition and the short name.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4289611","version":"2","preferredName":"Current Brain Neoplasm Primary Location Type","preferredDefinition":"The anatomic site or location type representing the primary location of the current brain cancer.","longName":"CUR_BR_NEO_PRI_LC_TP","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"39595704-BDA1-207B-E050-BB89AD436415","latestVersionIndicator":"Yes","beginDate":"2014-05-04","endDate":null,"createdBy":"SWEW","dateCreated":"2016-08-05","modifiedBy":"SWEW","dateModified":"2016-08-29","changeNote":"PBTC_WMS_050414 8/5/16 wms - changed from v1.0 to v2.0 to simplify the long name, to update the short name and definition.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4289615","version":"1.1","preferredName":"Initial Brain Neoplasm Primary Location Type","preferredDefinition":"The anatomic site or location type representing the primary location of the initial brain cancer.","longName":"INI_BR_NEO_PRI_LC_TP","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"39559C8D-CADD-4331-E050-BB89AD435E44","latestVersionIndicator":"Yes","beginDate":"2014-05-04","endDate":null,"createdBy":"SWEW","dateCreated":"2016-08-05","modifiedBy":"SWEW","dateModified":"2016-08-29","changeNote":"PBTC_WMS_050414 8/5/16 wms - CDE was versioned to update the definition and the data element short name.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4321931","version":"2","preferredName":"Initial Brain Neoplasm SNOMED-CT Anatomic Site Code","preferredDefinition":"The SNOMED code representing the primary anatomic location of initial brain cancer.","longName":"INI_BRNEO_SNOMED_ANA_CD","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3958DE03-DD00-E4F2-E050-BB89AD431FEA","latestVersionIndicator":"Yes","beginDate":"2014-05-19","endDate":null,"createdBy":"SWEW","dateCreated":"2016-08-05","modifiedBy":"SWEW","dateModified":"2016-08-29","changeNote":"PBTC_WMS_051914 8/5/16 wms - versioned CDE to simplify the long name, update the definition and short name.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4322013","version":"2","preferredName":"Current Brain Neoplasm SNOMED-CT Primary Anatomic Site Code","preferredDefinition":"The SNOMED code representing  the primary anatomic location of current brain cancer.","longName":"CUR_BRNEO_SNOMED_ANA_CD","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"395866B2-409F-4628-E050-BB89AD43031D","latestVersionIndicator":"Yes","beginDate":"2014-05-20","endDate":null,"createdBy":"SWEW","dateCreated":"2016-08-05","modifiedBy":"SWEW","dateModified":"2016-08-29","changeNote":"PBTC_WMS_052014 8/5/16 wms - versioned CDE to simplify the long name, update the definition and short name.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4337066","version":"1.1","preferredName":"Current Disease Diagnosis MedDRA Code","preferredDefinition":"The MedDRA code number for the diagnosis of the current state of a disease.","longName":"CUR_DZ_DX_MEDDRA_CD","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"39559C8D-CAAB-4331-E050-BB89AD435E44","latestVersionIndicator":"Yes","beginDate":"2014-05-28","endDate":null,"createdBy":"SWEW","dateCreated":"2016-08-05","modifiedBy":"SWEW","dateModified":"2016-08-29","changeNote":"PBTC_WMS_052814 8/5/16 wms - CDE was versioned with changes of the human readable definition and friendly short name.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4337095","version":"1.1","preferredName":"Initial Disease or Disorder Diagnosis MedDRA Code","preferredDefinition":"The MedDRA code number for the diagnosis of the initial state of a disease.","longName":"INI_DZ_DX_MEDDRA_CD","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"39AA92F5-61B2-CEA8-E050-BB89AD435F9E","latestVersionIndicator":"Yes","beginDate":"2014-05-28","endDate":null,"createdBy":"SWEW","dateCreated":"2016-08-09","modifiedBy":"SWEW","dateModified":"2016-08-29","changeNote":"PBTC_WMS_052814 8/9/16 wms - CDE was versioned to 1.1 to update the definition and Rave friendly short name.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4357915","version":"2","preferredName":"Current Brain Neoplasm Primary Anatomic Site Name","preferredDefinition":"The name of the site that specifies the primary anatomic location of the current brain cancer.","longName":"CUR_BR_NEO_PRI_ANAT_ST","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"39AB437D-C25D-5132-E050-BB89AD4333A6","latestVersionIndicator":"Yes","beginDate":"2014-06-12","endDate":null,"createdBy":"SWEW","dateCreated":"2016-08-09","modifiedBy":"SWEW","dateModified":"2016-08-29","changeNote":"PBTC_WMS_061214 8/9/16 wms - CDE was versioned to 2.0 to simplify the long name, to update the definition and the short name.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4357916","version":"1.1","preferredName":"Initial Brain Neoplasm Primary Specified Anatomic Site Name","preferredDefinition":"The name of the site that specifies the primary anatomic location of the initial brain cancer.","longName":"INI_BR_NEO_PRI_ANAT_ST","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"395AED47-9433-FA6D-E050-BB89AD436A1E","latestVersionIndicator":"Yes","beginDate":"2014-06-12","endDate":null,"createdBy":"SWEW","dateCreated":"2016-08-05","modifiedBy":"SWEW","dateModified":"2016-08-29","changeNote":"PBTC_WMS_061214 8/5/16 wms - CDE was versioned to 1.1 with an update of definition and friendly short name.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4503716","version":"1","preferredName":"Patient Negation Breast Feeding Indicator","preferredDefinition":"Yes No Not Applicable response regarding whether a patient has not been breastfeeding","longName":"PT_No_BR_FD_IND","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04777642-1A0D-6F0F-E050-BB89AD435407","latestVersionIndicator":"Yes","beginDate":"2014-10-02","endDate":null,"createdBy":"CARPSE","dateCreated":"2014-10-02","modifiedBy":"CARPSE","dateModified":"2014-10-02","changeNote":"PBTC044_10.02.2014_EC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4503771","version":"1","preferredName":"Neurological Assessment Performed Status","preferredDefinition":"The status response regarding the outcome of a neurologic exam performed","longName":"NEU_Perf_ST","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0477E8A3-A46C-0F54-E050-BB89AD43487A","latestVersionIndicator":"Yes","beginDate":"2014-10-02","endDate":null,"createdBy":"CARPSE","dateCreated":"2014-10-02","modifiedBy":"CARPSE","dateModified":"2014-10-02","changeNote":"PBTC044_10.02.2014_EC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4580873","version":"1","preferredName":"Dose Level Category","preferredDefinition":"information related to the dose level assignment of a protocol agent.","longName":"3597794v1.0:4580872v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"079ABC63-3B68-DA0F-E050-BB89AD435852","latestVersionIndicator":"Yes","beginDate":"2014-11-11","endDate":null,"createdBy":"LUOSHEN","dateCreated":"2014-11-11","modifiedBy":"HARTLEYG","dateModified":"2015-07-13","changeNote":"Released as part of the 3Q2015 draft content review_07.13.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4665463","version":"1","preferredName":"Performance Status Two Week Prior Enrollment Greater Than or Equal To Integer::50 Assessment Indicator","preferredDefinition":"The indicator response regarding whether a patient's performance status score is greater than or equal to 50 within 2 weeks prior to enrollment.","longName":"PER_ST_2W_ENR_50_IND","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0C9153ED-00AE-9F59-E050-BB89AD432091","latestVersionIndicator":"Yes","beginDate":"2015-01-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-01-13","modifiedBy":"HARTLEYG","dateModified":"2015-01-13","changeNote":"PBTC-044_PBTC_01.13.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4667095","version":"1","preferredName":"Patient Patient Radiation Therapy Induction Glioma Present Yes No Indicator","preferredDefinition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary._A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary._Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation._The act of bringing about something._A benign or malignant brain and spinal cord tumor that arises from glial cells (astrocytes, oligodendrocytes, ependymal cells). Tumors that arise from astrocytes are called astrocytic tumors or astrocytomas. Tumors that arise from oligodendrocytes are called oligodendroglial tumors. Tumors that arise from ependymal cells are called ependymomas._Being or existing in a specified place or at the specified time._The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"4667094v1.0:3506068v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0CA5D4C7-8AE4-0B05-E050-BB89AD430D0E","latestVersionIndicator":"Yes","beginDate":"2015-01-14","endDate":null,"createdBy":"CARPSE","dateCreated":"2015-01-14","modifiedBy":"CARPSE","dateModified":"2016-03-21","changeNote":"Released as part of the 3Q2015 draft content review_07.13.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4667115","version":"1","preferredName":"Pregnancy Pregnancy Education Counseling Event Date","preferredDefinition":"The state or condition of having a developing embryo or fetus in the body (uterus), after union of an ovum and spermatozoon, during the period from conception to birth._The state or condition of having a developing embryo or fetus in the body (uterus), after union of an ovum and spermatozoon, during the period from conception to birth._The activities of educating or instructing or teaching; activities that impart knowledge or skill._The act of receiving professional guidance in resolving personal conflicts and emotional problems._A particular day specified as the time something has, or will, happen.","longName":"Preg_Preg_Educ_Coun_EVT_DT","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0CA699C0-3B1A-53B4-E050-BB89AD430279","latestVersionIndicator":"Yes","beginDate":"2015-01-14","endDate":null,"createdBy":"CARPSE","dateCreated":"2015-01-14","modifiedBy":"HARTLEYG","dateModified":"2015-07-13","changeNote":"Released as part of the 3Q2015 draft content review_07.13.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4667137","version":"1","preferredName":"Brain Magnetic Resonance Imaging Diffusion Outcome Medical Imaging Status","preferredDefinition":"An organ composed of grey and white matter containing billions of neurons that is the center for intelligence and reasoning. It is protected by the bony cranium._Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide amazingly clear and detailed pictures of internal organs and tissues. The technique is valuable for the diagnosis of many pathologic conditions, including cancer, heart and vascular disease, stroke, and joint and musculoskeletal disorders._The movement of chemical species under the influence of a concentration difference and as a result of random thermal agitation. The species will move from the high concentration area to the low concentration area till the concentration is uniform in the whole phase._The result of an action._A condition or state at a particular time of a medical imaging procedure.","longName":"4667136v1.0:2555215v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0CA6EC96-CFD3-0FC7-E050-BB89AD437213","latestVersionIndicator":"Yes","beginDate":"2015-01-14","endDate":null,"createdBy":"CARPSE","dateCreated":"2015-01-14","modifiedBy":"HARTLEYG","dateModified":"2015-07-13","changeNote":"Released as part of the 3Q2015 draft content review_07.13.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4743043","version":"1","preferredName":"Brain Perfusion Magnetic Resonance Imaging Performed Date","preferredDefinition":"Brain which is an organ composed of grey and white matter containing billions of neurons that is the center for intelligence and reasoning which is protected by the bony cranium. Perfusion is a special type of magnetic resonance imaging (MRI) that uses an injected dye in order to see blood flow through tissues. Once executed and carried through to completion the date on which an observation was made or an event occurred is reported.","longName":"4743042v1.0:2018550v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"10F6F708-1E49-293C-E050-BB89AD4351B1","latestVersionIndicator":"Yes","beginDate":"2015-03-10","endDate":null,"createdBy":"RICHARDS","dateCreated":"2015-03-10","modifiedBy":"RICHARDS","dateModified":"2015-03-20","changeNote":"PBTC_SR","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4743050","version":"1","preferredName":"Brain Perfusion Magnetic Resonance Imaging Outcome Status","preferredDefinition":"Brain which is an organ composed of grey and white matter containing billions of neurons that is the center for intelligence and reasoning, protected by the bony cranium. Perfusion is a special type of magnetic resonance imaging (MRI) that uses an injected dye in order to see blood flow through tissues and provides the outcome information at the time of a medical imaging procedure.","longName":"4743046v1.0:2555215v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"10F72C05-25AB-7869-E050-BB89AD430868","latestVersionIndicator":"Yes","beginDate":"2015-03-10","endDate":null,"createdBy":"RICHARDS","dateCreated":"2015-03-10","modifiedBy":"RICHARDS","dateModified":"2015-03-20","changeNote":"PBTC_SR","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4743067","version":"1","preferredName":"Brain Magnetic Resonance Spectroscopic Imaging Performed Date","preferredDefinition":"The brain which is an organ composed of grey and white matter containing billions of neurons that is the center for intelligence and reasoning, protected by the bony cranium. Magnetic resonance spectroscopy is a noninvasive imaging technique that acts as a complement to conventional imaging of brain tumors in order to improve the sensitivity and specificity of the diagnostic process. This technique operates by exciting and recording signals from a range of magnetic resonance frequencies, allowing the identification and quantification of several biologically significant molecules containing proton groups that resonate in the appropriate frequency range. The technique facilitates observation of the spatial distribution of metabolic patterns over a region of interest and surrounding tissue at a high spatial resolution. Once executed and carried through to completion the date on which an observation was made or an event occurred is reported.","longName":"4743061v1.0:2018550v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"10F72C05-25EE-7869-E050-BB89AD430868","latestVersionIndicator":"Yes","beginDate":"2015-03-10","endDate":null,"createdBy":"RICHARDS","dateCreated":"2015-03-10","modifiedBy":"RICHARDS","dateModified":"2015-03-20","changeNote":"PBTC_SR","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4743077","version":"1","preferredName":"Brain Magnetic Resonance Spectroscopic Imaging Outcome Status","preferredDefinition":"The brain which is an organ composed of grey and white matter containing billions of neurons that is the center for intelligence and reasoning, protected by the bony cranium. Magnetic resonance spectroscopy is a noninvasive imaging technique that acts as a complement to conventional imaging of brain tumors in order to improve the sensitivity and specificity of the diagnostic process. This technique operates by exciting and recording signals from a range of magnetic resonance frequencies, allowing the identification and quantification of several biologically significant molecules containing proton groups that resonate in the appropriate frequency range. The technique facilitates observation of the spatial distribution of metabolic patterns over a region of interest and surrounding tissue at a high spatial resolution and provides the outcome information of a medical imaging procedure.","longName":"4743071v1.0:2555215v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"10F7D22C-3476-57F5-E050-BB89AD434288","latestVersionIndicator":"Yes","beginDate":"2015-03-10","endDate":null,"createdBy":"RICHARDS","dateCreated":"2015-03-10","modifiedBy":"RICHARDS","dateModified":"2015-03-20","changeNote":"PBTC_SR","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4743671","version":"1","preferredName":"Human Immunodeficiency Virus Diagnosis Indicator","preferredDefinition":"The permissible values of yes/no/not applicable to indicate whether there is a diagnosis of Human Immunodeficiency Virus (HIV).","longName":"2195690v1.0:3506036v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"110A3CAC-7209-AEC8-E050-BB89AD437FE8","latestVersionIndicator":"Yes","beginDate":"2015-03-11","endDate":null,"createdBy":"RICHARDS","dateCreated":"2015-03-11","modifiedBy":"KUMMEROA","dateModified":"2023-03-28","changeNote":"PBTC_SR","administrativeNotes":"2023.3.28 AQT added per ticket request CADSR0002164. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4888831","version":"1","preferredName":"Patient Trial Screening Consent And Blood Sample Submission HLA Typing Clinical Trial Eligibility Criteria","preferredDefinition":"A yes or no coded response indicating whether a patient meets the criteria for enrollment into a clinical trial with regard to consent for HLA typing for purposes of screening.","longName":"4886914v1.0:3506068v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"19AD70A5-A402-9750-E050-BB89AD434212","latestVersionIndicator":"Yes","beginDate":"2015-06-29","endDate":null,"createdBy":"RICHARDS","dateCreated":"2015-06-29","modifiedBy":"RICHARDS","dateModified":"2015-07-10","changeNote":"PBTC SR 062915","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4889031","version":"1","preferredName":"Patient Newly Diagnosed Diffuse Intrinsic Pontine Glioma Clinical Trial Eligibility Criteria Yes No Indicator","preferredDefinition":"A yes or no coded response indicating whether a patient has a newly diagnosed DIPG which meets the criteria for enrollment into a clinical trial .","longName":"4886926v1.0:3506068v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"19BD1E51-4299-A1B4-E050-BB89AD4335E1","latestVersionIndicator":"Yes","beginDate":"2015-06-30","endDate":null,"createdBy":"RICHARDS","dateCreated":"2015-06-30","modifiedBy":"RICHARDS","dateModified":"2021-11-08","changeNote":"PBTC sr 063015","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4889056","version":"1","preferredName":"Patient Newly Diagnosed Negation Brain Stem Intracranial High Grade Glioma Histologic Confirmation Clinical Trial Eligibility Criteria Yes No Indicator","preferredDefinition":"A yes or no indicator coded response indicating whether a patient meets the criteria for enrollment into a clinical trial by having a histologically confirmed non-brainstem intracranial high grade glioma.","longName":"4886977v1.0:3506068v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"19BD85B5-D2E5-369D-E050-BB89AD4336E8","latestVersionIndicator":"Yes","beginDate":"2015-06-30","endDate":null,"createdBy":"RICHARDS","dateCreated":"2015-06-30","modifiedBy":"RICHARDS","dateModified":"2015-07-09","changeNote":"PBTC sr 063015","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4889143","version":"1","preferredName":"Patient Glioblastoma Anaplastic Astrocytoma Gliosarcoma Glioma   Fibrillary Astrocytoma Histologic Confirmation Clinical Trial Eligibility Criteria Yes No Not Applicable Indicator","preferredDefinition":"A yes or no or NA coded response indicating whether a patient with DIPG meets the criteria for enrollment into a clinical trial by having a histologically confirmed diagnosis of glioblastoma, anaplastic astrocytoma, gliocarcoma, glioma or fibrillary astrocytoma.","longName":"4886933v1.0:3506036v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"19BE28E4-965D-AD70-E050-BB89AD435672","latestVersionIndicator":"Yes","beginDate":"2015-06-30","endDate":null,"createdBy":"RICHARDS","dateCreated":"2015-06-30","modifiedBy":"RICHARDS","dateModified":"2017-04-26","changeNote":"PBTC sr 063015","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4889171","version":"1","preferredName":"Patient HLA Class I Histocompatibility Antigen, A-2 Alpha Chain Positive Finding Clinical Trial Eligibility Criteria  Yes No Indicator","preferredDefinition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary._HLA class I histocompatibility antigen, A-2 alpha chain (365 aa, ~41 kDa) is encoded by the human HLA-A gene. This protein is involved in antigen presentation._A quantity having a value greater than zero._Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria._An observation confirming something, such as the presence of a disease, condition, or microorganism._The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"4886995v1.0:3506068v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"19BE28E4-968D-AD70-E050-BB89AD435672","latestVersionIndicator":"Yes","beginDate":"2015-06-30","endDate":null,"createdBy":"RICHARDS","dateCreated":"2015-06-30","modifiedBy":"RICHARDS","dateModified":"2015-07-09","changeNote":"PBTC sr 063015","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4889175","version":"1","preferredName":"Patient Surgical Procedure Corticosteroid Administration Exception No Prior Therapy Clinical Trial Eligibility Criteria Yes No Indicator","preferredDefinition":"A yes or no coded response indicating whether a patient meets the criteria for enrollment into a clinical trial by having no prior therapy with the exception of surgery and/or corticosteroids.","longName":"4887014v1.0:3506068v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"19BE28E4-9777-AD70-E050-BB89AD435672","latestVersionIndicator":"Yes","beginDate":"2015-06-30","endDate":null,"createdBy":"RICHARDS","dateCreated":"2015-06-30","modifiedBy":"RICHARDS","dateModified":"2015-10-08","changeNote":"PBTC sr 063015","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4889177","version":"1","preferredName":"Patient Metastatic Disease Clinical Trial Eligibility Criteria Yes No Indicator","preferredDefinition":"A yes or no coded response indicating whether a patient meets the criteria for enrollment into a clinical trial by having no evidence of metastatic disease.","longName":"4794116v1.0:3506068v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"19BE28E4-9797-AD70-E050-BB89AD435672","latestVersionIndicator":"Yes","beginDate":"2015-06-30","endDate":"2015-07-09","createdBy":"RICHARDS","dateCreated":"2015-06-30","modifiedBy":"SPRINGERL","dateModified":"2021-12-10","changeNote":"10.20.2020 Moved from RETIRED WITHDRAWN to RETIRED ARCHIVED in preparation of MDR; TL.; PBTC sr 063015; unretired CDE for COG 11/23/2021 bsm.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4889211","version":"1","preferredName":"Patient High Grade Glioma Gross Complete Excision Clinical Trial Eligibility Criteria Yes No Not Applicable Indicator","preferredDefinition":"A yes or no coded response indicating whether a patient with HGG meets the criteria for enrollment into a clinical trial by not having undergone a gross total resection","longName":"4887036v1.0:3506036v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"19BE28E4-97F3-AD70-E050-BB89AD435672","latestVersionIndicator":"Yes","beginDate":"2015-06-30","endDate":null,"createdBy":"RICHARDS","dateCreated":"2015-06-30","modifiedBy":"RICHARDS","dateModified":"2015-07-09","changeNote":"PBTC sr 063015","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4889711","version":"1","preferredName":"Patient Prior Interleukin Administration Clinical Trial Eligibility Criteria Administration Yes No Indicator","preferredDefinition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary._Interleukin is the generic name for a group of well-characterized cytokines that are produced by leukocytes and other cell types.  They have a broad spectrum of functional activities that regulate the activities and capabilities of a wide variety of cell types.  They are particularly important as members of the cytokine networks that regulate inflammatory and immune responses._The act of the dispensing, applying, or tendering of something to another, such as administration of a medicine._An indication or description that medications were taken previously._Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria._Earlier in time or order._Interleukin is the generic name for a group of well-characterized cytokines that are produced by leukocytes and other cell types.  They have a broad spectrum of functional activities that regulate the activities and capabilities of a wide variety of cell types.  They are particularly important as members of the cytokine networks that regulate inflammatory and immune responses._The act of the dispensing, applying, or tendering of something to another, such as administration of a medicine._The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"4887053v1.0:3506068v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"19C05E2B-DBA8-BD93-E050-BB89AD430F18","latestVersionIndicator":"Yes","beginDate":"2015-06-30","endDate":null,"createdBy":"RICHARDS","dateCreated":"2015-06-30","modifiedBy":"RICHARDS","dateModified":"2015-07-09","changeNote":"PBTC sr 063015","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4889759","version":"1","preferredName":"Patient Allergy Shot Administration Clinical Trial Eligibility Criteria Yes No Indicator","preferredDefinition":"A yes or no coded response indicating whether a patient meets criteria for enrollment into a clinical trial by having not received allergy desensitization shots just prior to enrollment","longName":"4889756v1.0:3506068v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"19C05E2B-DC62-BD93-E050-BB89AD430F18","latestVersionIndicator":"Yes","beginDate":"2015-06-30","endDate":null,"createdBy":"RICHARDS","dateCreated":"2015-06-30","modifiedBy":"RICHARDS","dateModified":"2015-10-08","changeNote":"PBTC sr 063015","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4891254","version":"1","preferredName":"Patient Investigational New Drug Therapeutic Procedure Clinical Trial Eligibility Criteria Yes No Indicator","preferredDefinition":"A yes or no coded response indicating whether a patient meets criteria for enrollment into a clinical trial by indicating they are not receiving any other investigational agents.","longName":"4891253v1.0:3506068v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1A3BA5F0-E3EA-ECB7-E050-BB89AD43540C","latestVersionIndicator":"Yes","beginDate":"2015-07-06","endDate":null,"createdBy":"RICHARDS","dateCreated":"2015-07-06","modifiedBy":"RICHARDS","dateModified":"2015-07-06","changeNote":"PBTC sr 070615","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4924231","version":"1","preferredName":"Disease Response Neurologic New or Worsening Symptom Intubation Procedure Pressor Support Pseudoprogression Assessment Pseudoprogression Yes No Indicator","preferredDefinition":"A yes or no response indicating whether a patient has been assessed for pseudoprogression which is recognized by worsening symptoms which require intubation and/or pressor support.","longName":"4896217v1.0:3506068v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1BF49271-6890-CC77-E050-BB89AD434ADA","latestVersionIndicator":"Yes","beginDate":"2015-07-28","endDate":null,"createdBy":"RICHARDS","dateCreated":"2015-07-28","modifiedBy":"RICHARDS","dateModified":"2015-07-28","changeNote":"PBTC slr 072815","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"4985972","version":"1","preferredName":"Regimen-Limiting Toxicity Indicator Yes No Indicator","preferredDefinition":"Indication (Y or No) of an adverse event considered to be a regimen-limiting toxicity. .","longName":"4985953v1.0:3506068v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E394406-999A-29FD-E050-BB89AD437682","latestVersionIndicator":"Yes","beginDate":"2015-08-26","endDate":null,"createdBy":"RICHARDS","dateCreated":"2015-08-26","modifiedBy":"KUMMEROA","dateModified":"2022-09-13","changeNote":"PBTC_sr082615","administrativeNotes":"2022.9.13 AQT and Alt SN added for ticket request CADSR0001486. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5023495","version":"1","preferredName":"Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed Personal Medical History Yes No Indicator","preferredDefinition":"Text indicator to represent a record of a person's inoculation with DPT vaccine.","longName":"5023494v1.0:3506068v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"205F0028-EEFF-27F9-E050-BB89AD436A35","latestVersionIndicator":"Yes","beginDate":"2015-09-22","endDate":null,"createdBy":"RICHARDS","dateCreated":"2015-09-22","modifiedBy":"RICHARDS","dateModified":"2015-09-22","changeNote":"PBTC slr092215","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5036335","version":"1","preferredName":"Patient Disease Progression Diffuse Intrinsic Pontine Glioma Clinical Trial Eligibility Criteria Yes No Indicator","preferredDefinition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary._The worsening of a disease over time._A neuroglial tumor that arises from the middle portion of the brain stem. It usually affects children and has a poor prognosis._Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria._The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"5036333v1.0:3506068v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"228C30EA-7C8A-39E8-E050-BB89AD437985","latestVersionIndicator":"Yes","beginDate":"2015-10-20","endDate":null,"createdBy":"CARPSE","dateCreated":"2015-10-20","modifiedBy":"RICHARDS","dateModified":"2021-12-16","changeNote":"PBTC 047_10.15.20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5046711","version":"1","preferredName":"Patient Consent Brief Steroid Therapy Inflammatory Response Clinical Trial Eligibility Criteria Yes No Indicator","preferredDefinition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary._Permission to do something._Of short duration, extent, or distance._Treatment with corticosteroid drugs to reduce swelling, pain, and other symptoms of inflammation._A part of innate immunity, the Inflammatory Response occurs when injured tissues induce release of vasodilatory, opsonizing, and chemotactic mediators that attract macrophages and leukocytes to phagocytize and destroy foreign substances; dilate local blood vessels increasing local blood flow; increase capillary permeability; produce edematous swelling; and induce pain. Plasma- and cell-derived inflammatory mediators include Prostaglandins, Leukotrines, Cytokines, Lymphokines, Monokines, PAF, Histamine, Bradykinin, Complement, and Interferons._Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria._The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"5046434v1.0:3506068v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"24D4A71D-2773-4D11-E050-BB89AD430262","latestVersionIndicator":"Yes","beginDate":"2015-11-18","endDate":null,"createdBy":"RICHARDS","dateCreated":"2015-11-18","modifiedBy":"RICHARDS","dateModified":"2021-07-21","changeNote":"PBTC 18Nov2015_slr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5046712","version":"1","preferredName":"Patient Bulk Neoplasm Definition Clinical Study Protocol Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"The response which indicates whether or not a person meets the requirements for participation in a clinical trial regarding bulky disease as described in the protocol","longName":"Bulky_Disease","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"24D4C0C0-CB1C-3D92-E050-BB89AD4376B5","latestVersionIndicator":"Yes","beginDate":"2015-11-18","endDate":null,"createdBy":"RICHARDS","dateCreated":"2015-11-18","modifiedBy":"RICHARDS","dateModified":"2021-07-21","changeNote":"PBTC 18Nov2015_slr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5046714","version":"1","preferredName":"Patient Adverse Event Associated with Surgery and Intra-Operative Injury Recovered or Resolved Clinical Trial Eligibility Criteria Yes No Not Applicable Indicator","preferredDefinition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary._An adverse event associated with surgery or an intra-operative injury._One of the possible results of an adverse event outcome that indicates that the event has improved or recuperated._Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria._The preferred Value Domain to indicate a question with permissible values of yes/no/not applicable.","longName":"5046440v1.0:3506068v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"24D4C0C0-CB3C-3D92-E050-BB89AD4376B5","latestVersionIndicator":"Yes","beginDate":"2015-11-18","endDate":null,"createdBy":"RICHARDS","dateCreated":"2015-11-18","modifiedBy":"KUMMEROA","dateModified":"2023-09-15","changeNote":"PBTC-051","administrativeNotes":"2023.9.15 Updated def for 'No Value Exists'. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5046731","version":"1","preferredName":"Brain Magnetic Resonance Imaging Diffusion Outcome Assessment Performed Status","preferredDefinition":"An organ composed of grey and white matter containing billions of neurons that is the center for intelligence and reasoning. It is protected by the bony cranium._Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide amazingly clear and detailed pictures of internal organs and tissues. The technique is valuable for the diagnosis of many pathologic conditions, including cancer, heart and vascular disease, stroke, and joint and musculoskeletal disorders._The movement of chemical species under the influence of a concentration difference and as a result of random thermal agitation. The species will move from the high concentration area to the low concentration area till the concentration is uniform in the whole phase._The result of an action._The condition or state of an evaluation being performed at a particular time.","longName":"4667136v1.0:2528343v2.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"24D4C0C0-CB61-3D92-E050-BB89AD4376B5","latestVersionIndicator":"Yes","beginDate":"2015-11-18","endDate":null,"createdBy":"RICHARDS","dateCreated":"2015-11-18","modifiedBy":"RICHARDS","dateModified":"2015-11-18","changeNote":"PBTC 18Nov2015_slr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5046751","version":"1","preferredName":"Brain Perfusion Magnetic Resonance Imaging Outcome Assessment Performed Status","preferredDefinition":"An organ composed of grey and white matter containing billions of neurons that is the center for intelligence and reasoning. It is protected by the bony cranium._A special type of magnetic resonance imaging (MRI) that uses an injected dye in order to see blood flow through tissues._The result of an action._The condition or state of an evaluation being performed at a particular time.","longName":"4743046v1.0:2528343v2.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"24D5D2EB-DD32-6E78-E050-BB89AD434DEA","latestVersionIndicator":"Yes","beginDate":"2015-11-18","endDate":null,"createdBy":"RICHARDS","dateCreated":"2015-11-18","modifiedBy":"RICHARDS","dateModified":"2015-11-18","changeNote":"PBTC 18Nov2015_slr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5046778","version":"1","preferredName":"Brain Magnetic Resonance Spectroscopic Imaging Outcome Assessment Performed Status","preferredDefinition":"An organ composed of grey and white matter containing billions of neurons that is the center for intelligence and reasoning. It is protected by the bony cranium._Magnetic resonance spectroscopy is a noninvasive imaging technique that acts as a complement to conventional imaging of brain tumors in order to improve the sensitivity and specificity of the diagnostic process. This technique operates by exciting and recording signals from a range of magnetic resonance frequencies, allowing the identification and quantification of several biologically significant molecules containing proton groups that resonate in the appropriate frequency range. The technique facilitates observation of the spatial distribution of metabolic patterns over a region of interest and surrounding tissue at a high spatial resolution._The result of an action._The condition or state of an evaluation being performed at a particular time.","longName":"4743071v1.0:2528343v2.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"24D69061-AA48-7D75-E050-BB89AD434E09","latestVersionIndicator":"Yes","beginDate":"2015-11-18","endDate":null,"createdBy":"RICHARDS","dateCreated":"2015-11-18","modifiedBy":"RICHARDS","dateModified":"2015-11-20","changeNote":"PBTC 18Nov2015_slr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5046801","version":"1","preferredName":"Patient Informed Consent Version  Timepoint Protocol Version","preferredDefinition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary._Consent by a patient to a surgical or medical procedure or participation in a clinical study after achieving an understanding of the relevant medical facts and the risks involved._A form or variant of a type or original; one of a sequence of copies of a program, each incorporating new modifications._The act of registration, entering in a list, catalog, group, study; also, the number of subjects enrolled._A specific point in the time continuum, including those established relative to an event._The text that describes the generation of the protocol.","longName":"5046528v1.0:5046797v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"24D72064-ABB2-2F4C-E050-BB89AD433482","latestVersionIndicator":"No","beginDate":"2015-11-18","endDate":null,"createdBy":"RICHARDS","dateCreated":"2015-11-18","modifiedBy":"RICHARDS","dateModified":"2016-07-25","changeNote":"PBTC 18Nov2015_slr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5046801","version":"2","preferredName":"Patient Informed Consent Timepoint Protocol Version Number","preferredDefinition":"Protocol version number  of a consent signed at a timepoint by a patient for a surgical or medical procedure or participation in a clinical study after achieving an understanding of the relevant medical facts and the risks involved.","longName":"5046528v1.0:5046797v2.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"387ABC6F-4237-4134-E050-BB89AD433909","latestVersionIndicator":"Yes","beginDate":"2016-07-25","endDate":null,"createdBy":"RICHARDS","dateCreated":"2016-07-25","modifiedBy":"RICHARDS","dateModified":"2016-07-25","changeNote":"PBTC 25 July 2016 Version 2.0  due to updating the definition to human readable and a new version of the VD.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5047594","version":"1","preferredName":"Off Treatment Primary Associated Adverse Event Common Terminology Criteria for Adverse Events Version Integer::4.0 Low Level Term Name","preferredDefinition":"When a patient is not receiving therapy they are considered off treatment.  In clinical trials, a dosing schedule may require a patient to stop medication for a period of time, then resume, such as 28 days on and 7 days off._Occurring first in time or sequence; original; of greatest rank or importance or value._Joined in some kind of relationship._Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s)._A standard terminology of low level terms developed to report adverse events occurring in cancer clinical trials.","longName":"5047593v1.0:3125301v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"24ED6A42-553D-BBCD-E050-BB89AD43396B","latestVersionIndicator":"Yes","beginDate":"2015-11-19","endDate":null,"createdBy":"RICHARDS","dateCreated":"2015-11-19","modifiedBy":"RICHARDS","dateModified":"2015-11-19","changeNote":"PBTC 19Nov2015_slr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5050572","version":"1","preferredName":"Specimen Collection Period Chemotherapy Course Day Timepoint Type","preferredDefinition":"The response that indicates the chemotherapy course day combination for specimen collection.","longName":"SPEC_COL_CRS_DY_TMPT_TYP","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"24FE5F91-2E91-5949-E050-BB89AD430D80","latestVersionIndicator":"Yes","beginDate":"2015-11-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-11-20","modifiedBy":"CARPSE","dateModified":"2015-11-20","changeNote":"PTBC047_11.20.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5075851","version":"1","preferredName":"Patient Specimen Tissue Collection Consent Yes No Indicator","preferredDefinition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary._A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis._A repository of the tissue specimen, cells or cell lines, for experimental purpose. It can be from different diseases or different parts of the body._Permission to do something._The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"5075814v1.0:3506068v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"261A949D-5EB8-0953-E050-BB89AD437F39","latestVersionIndicator":"Yes","beginDate":"2015-12-04","endDate":null,"createdBy":"RICHARDS","dateCreated":"2015-12-04","modifiedBy":"RICHARDS","dateModified":"2015-12-04","changeNote":"PBTC 120415 slr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5075874","version":"1.1","preferredName":"Patient Future Research Activity Remaining Specimen Consent Yes No Indicator","preferredDefinition":"The response that indicates whether a patient has consented to allow future research on remaining specimens.","longName":"5075833v1.0:3506068v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4B6C146F-3946-6256-E053-F662850ABDA8","latestVersionIndicator":"Yes","beginDate":"2017-03-23","endDate":null,"createdBy":"RICHARDS","dateCreated":"2017-03-23","modifiedBy":"SOKKERL","dateModified":"2017-07-25","changeNote":"PBTC 032317 - updated with human readable definition","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5094538","version":"1","preferredName":"Participant Consent Correlative Study Consent Type","preferredDefinition":"A type of study that tests for a relationship between a condition and a potential causal factor of the condition._Permission to do something._Something distinguishable as an identifiable class based on common qualities.","longName":"2634451v1.0:5094391v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2796F431-2CEC-87F5-E050-BB89AD43578E","latestVersionIndicator":"Yes","beginDate":"2015-12-23","endDate":null,"createdBy":"RICHARDS","dateCreated":"2015-12-23","modifiedBy":"RICHARDS","dateModified":"2019-09-13","changeNote":"PBTC 122315 slr PV updated 091416 slr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5097291","version":"1","preferredName":"Specimen Container Type Container Type","preferredDefinition":"A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis._An object that can be used to hold things._Something distinguishable as an identifiable class based on common qualities._An object that can be used to hold things._Something distinguishable as an identifiable class based on common qualities.","longName":"5097212v1.0:5097214v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"28C1A93C-10AE-A5D9-E050-BB89AD435540","latestVersionIndicator":"Yes","beginDate":"2016-01-07","endDate":null,"createdBy":"RICHARDS","dateCreated":"2016-01-07","modifiedBy":"RICHARDS","dateModified":"2016-01-07","changeNote":"PBTC 010716 sr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5097354","version":"1","preferredName":"Specimen Submitted Type","preferredDefinition":"information related to a specimen being submitted._A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis._The act of referring for judgment or consideration by others; the act of handing over something._Something distinguishable as an identifiable class based on common qualities.","longName":"2014625v1.0:5097191v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"28C2FB08-2FE0-1918-E050-BB89AD433444","latestVersionIndicator":"Yes","beginDate":"2016-01-07","endDate":null,"createdBy":"RICHARDS","dateCreated":"2016-01-07","modifiedBy":"RICHARDS","dateModified":"2016-01-07","changeNote":"PBTC sr 010716","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5119171","version":"1","preferredName":"Central Nervous System Disease or Disorder Response Date","preferredDefinition":"The part of the nervous system that consists of the brain, spinal cord, and meninges._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._Any act or phenomena, or behavior, constituting a reply or reaction of a living organism or its part to some foregoing stimulus or agent._the date on which an observation was made or an event occurred.","longName":"4253105v1.0:2018550v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2B46A5C5-9F6A-CEEA-E050-BB89AD430303","latestVersionIndicator":"Yes","beginDate":"2016-02-08","endDate":null,"createdBy":"RICHARDS","dateCreated":"2016-02-08","modifiedBy":"RICHARDS","dateModified":"2016-02-08","changeNote":"PBTC_slr_02082016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5123296","version":"1","preferredName":"Agent Change Change Outcome","preferredDefinition":"The act of alteration or modification of an agent, an active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect._The act of alteration or modification; changed or altered in form or character._The result of an action.","longName":"2186047v2.0:5123292v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2BE64C73-EB00-1DF1-E050-BB89AD431FB5","latestVersionIndicator":"Yes","beginDate":"2016-02-16","endDate":null,"createdBy":"RICHARDS","dateCreated":"2016-02-16","modifiedBy":"RICHARDS","dateModified":"2016-02-22","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5152992","version":"1","preferredName":"Tissue Sample Normal Control Collection Event Day Name","preferredDefinition":"A piece of tissue removed from an organism for examination, analysis, or propagation._Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm. (NCI)_The act of directing or determining; regulation or maintenance of a function or action; a relation of constraint of one entity (thing or person or group) by another._The act of gathering something together._Something that happens at a given place and time._The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day._To determine the number or amount of something; the result of this activity.","longName":"3288194v2.0:5152991v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2D913440-6A90-3388-E050-BB89AD4311ED","latestVersionIndicator":"Yes","beginDate":"2016-03-08","endDate":null,"createdBy":"RICHARDS","dateCreated":"2016-03-08","modifiedBy":"COBARRUBIAK","dateModified":"2021-07-08","changeNote":"PBTC slr030816","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5153874","version":"1","preferredName":"Protocol Course Number Event Course Name","preferredDefinition":"Numeric value assigned to identify a period of protocol activity; a course is comprised of multiple cycles of protocol-dictated activities. [Manually-curated]_Something that happens at a given place and time._Passage through time; duration; a systematic or/and orderly succession; a sequence, e.g. course of treatment; a mode of action or behavior; natural development, typical manner of proceeding._The words or language units by which a thing is known.","longName":"2732182v1.0:5153872v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2DB44026-2010-5417-E050-BB89AD437B53","latestVersionIndicator":"Yes","beginDate":"2016-03-10","endDate":null,"createdBy":"RICHARDS","dateCreated":"2016-03-10","modifiedBy":"RICHARDS","dateModified":"2017-05-10","changeNote":"PBTC slr 031016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5255988","version":"1","preferredName":"Prior BMSCT Administered Indicator","preferredDefinition":"An indicator of Yes/No/NA to signify that the participant has received bone marrow/stem cell transplant prior to enrollment on  a trial.","longName":"PRIOR_BMSCT_ADM_IND","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3294367F-67DE-E1AC-E050-BB89AD431559","latestVersionIndicator":"Yes","beginDate":"2016-05-11","endDate":null,"createdBy":"SWEW","dateCreated":"2016-05-11","modifiedBy":"HARTLEYG","dateModified":"2016-08-29","changeNote":"PBTC_WMS_051116","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5256058","version":"1","preferredName":"Person Radiation Therapy Discontinued Prior Registration Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"A yes/no/not applicable response indicating whether a person has discontinued any treatment of a disease by means of exposure of the target or the whole body to radiation prior to registration as an element of a personal medical history which is necessary to allow an individual to participate in a specific clinical trial.","longName":"RX_TX_DIS_CTEC_IND","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3294B563-7314-7E9A-E050-BB89AD435E12","latestVersionIndicator":"Yes","beginDate":"2016-05-11","endDate":null,"createdBy":"SWEW","dateCreated":"2016-05-11","modifiedBy":"SWEW","dateModified":"2016-08-29","changeNote":"PBTC_WMS_051116: curated as part of the amendment.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5256247","version":"1","preferredName":"Radiation Therapy Prior Craniospinal Administered Indicator","preferredDefinition":"A yes/no/not applicable response indicating if patient has received prior Craniospinal radiation therapy.","longName":"PRIOR_CS_RAD_THP_ADM_IND","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3295209A-7CCC-55EE-E050-BB89AD43085B","latestVersionIndicator":"Yes","beginDate":"2016-05-11","endDate":null,"createdBy":"SWEW","dateCreated":"2016-05-11","modifiedBy":"SWEW","dateModified":"2016-08-29","changeNote":"PBTC_WMS_051116","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5261039","version":"1","preferredName":"Patient Prior Treatment Regimen And Or Radiation Therapy Receive Clinical Trial Eligibility Indicator","preferredDefinition":"The yes or no response indicating whether or not a patient has received prior treatment regimen and/or radiation therapy that meet the criteria for participation in a clinical trial.","longName":"PT_PRI_TREG_RT_IND","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"32C0B5E2-DAD1-C8E7-E050-BB89AD436E55","latestVersionIndicator":"Yes","beginDate":"2016-05-13","endDate":null,"createdBy":"SWEW","dateCreated":"2016-05-13","modifiedBy":"HARTLEYG","dateModified":"2016-08-29","changeNote":"PBTC_WMS_051316 (curated as part of 042_v4 checklist)","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5270291","version":"1","preferredName":"Patient Prior Treatment Regimen And Or Craniospinal Radiation Therapy And Or Bone Marrow Stem Cell Transplantation Receive Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"The yes/no indicator related to criteria to determine eligibility whether a patient has received any prior treatment regimen and/or craniospinal irradiation and/or bone marrow stem cell transplantation.","longName":"P_TXR_CSRT_BMSCT_REC","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"33100476-75D6-ADF2-E050-BB89AD431C75","latestVersionIndicator":"Yes","beginDate":"2016-05-17","endDate":null,"createdBy":"SWEW","dateCreated":"2016-05-17","modifiedBy":"SWEW","dateModified":"2016-05-19","changeNote":"PBTC_WMS_051716","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5270314","version":"1","preferredName":"Patient Histologically Confirmation Retinoblastoma-Associated Protein Positive Finding Central Nervous System Disease or Disorder Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"The yes/no/not applicable response regarding whether a patient with a central nervous system tumor has histologically confirmed Rb1 positive finding that meets the criteria to participate in a clinical trial.","longName":"HIS_RB_POS_CNS_DS_EC","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"331184B9-95AF-D09A-E050-BB89AD432444","latestVersionIndicator":"Yes","beginDate":"2016-05-17","endDate":null,"createdBy":"SWEW","dateCreated":"2016-05-17","modifiedBy":"SWEW","dateModified":"2016-05-19","changeNote":"PBTC_WMS_051716","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5329923","version":"1","preferredName":"Patient Sustained Symptomatic Ventricular Arrhythmia Uncontrolled Pharmacotherapy Medical Device Eligibility Determination Yes No Unknown Not Applicable Indicator","preferredDefinition":"a yes/no/unknown/not applicable indicator related to eligibility of a patient who receives medical attention, care, or treatment, exhibiting the sustained or symptomatic disease, relating to any variation from the normal rate or rhythm in the heart, which is not controlled, regulated, or constrained through the use of drugs or treatment.","longName":"SustndSxDysrhythUncontrll","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"366D3236-95A6-BF6D-E050-BB89AD4360E2","latestVersionIndicator":"Yes","beginDate":"2016-06-29","endDate":null,"createdBy":"SHUJIEH","dateCreated":"2016-06-29","modifiedBy":"SHUJIEH","dateModified":"2016-07-07","changeNote":"PBTC-048","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5332730","version":"1","preferredName":"Patient Skull Defect Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"The yes/no indicator related to eligibility of a patient who has skull defects.","longName":"5332725v1.0:3506068v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"36720BF8-ED08-678D-E050-BB89AD436736","latestVersionIndicator":"Yes","beginDate":"2016-06-29","endDate":null,"createdBy":"SHUJIEH","dateCreated":"2016-06-29","modifiedBy":"SHUJIEH","dateModified":"2016-07-06","changeNote":"PBTC_SH 06/29/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5333492","version":"1","preferredName":"Patient Head Circumference Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"The yes no indicator related to the measurement of patient head, which is necessary to allow a patient to participate in a clinical study.","longName":"5333489v1.0:3506068v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"368117F6-6377-43BD-E050-BB89AD435BF7","latestVersionIndicator":"Yes","beginDate":"2016-06-30","endDate":null,"createdBy":"SHUJIEH","dateCreated":"2016-06-30","modifiedBy":"SHUJIEH","dateModified":"2016-08-31","changeNote":"PBTC-048","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5333669","version":"1","preferredName":"Patient Device Usage Indicator","preferredDefinition":"The Yes No indicator reflects whether the patient is compliant with device usage.","longName":"5333658v1.0:3506068v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3682712A-9911-931C-E050-BB89AD43660C","latestVersionIndicator":"Yes","beginDate":"2016-06-30","endDate":null,"createdBy":"SHUJIEH","dateCreated":"2016-06-30","modifiedBy":"RICHARDS","dateModified":"2022-01-07","changeNote":"PBTC-048","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5333894","version":"1","preferredName":"Patient Infratentorial Neoplasm Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"The yes no indicator related to the brain tumor locations, which are necessary to allow a patient to participate in a clinical study.","longName":"5333893v1.0:3506068v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"368451BF-44B2-41B0-E050-BB89AD4365F8","latestVersionIndicator":"Yes","beginDate":"2016-06-30","endDate":null,"createdBy":"SHUJIEH","dateCreated":"2016-06-30","modifiedBy":"SHUJIEH","dateModified":"2020-08-04","changeNote":"PBTC-048","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5333903","version":"1","preferredName":"Skull Missing Indicator","preferredDefinition":"The yes/no indicator related to weather the bones of the braincase and face are not existing.","longName":"5333902v1.0:3506068v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"368473D8-C46A-B58D-E050-BB89AD431BF8","latestVersionIndicator":"Yes","beginDate":"2016-06-30","endDate":null,"createdBy":"SHUJIEH","dateCreated":"2016-06-30","modifiedBy":"SHUJIEH","dateModified":"2016-07-05","changeNote":"PBTC-048","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5333914","version":"1","preferredName":"Patient Active Implanted Medical Device Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"The yes/no indicator related to if patient has active implanted electronic devices in the brain or spinal cord, which are necessary to allow a patient to participate in a clinical study.","longName":"5333913v1.0:3506068v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3684D5E9-FEB1-CEBE-E050-BB89AD433AFA","latestVersionIndicator":"Yes","beginDate":"2016-06-30","endDate":null,"createdBy":"SHUJIEH","dateCreated":"2016-06-30","modifiedBy":"SHUJIEH","dateModified":"2016-07-06","changeNote":"PBTC-048","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5334508","version":"1","preferredName":"Patient Intracranial Foreign Body Clinical Trial Eligibility Criteria Indicator","preferredDefinition":"The yes/no indicator related to whether patient has foreign body intracranially, which is necessary to allow a subject to participate in a clinical study.","longName":"5333993v1.0:3506068v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"36995893-B631-4289-E050-BB89AD434BDC","latestVersionIndicator":"Yes","beginDate":"2016-07-01","endDate":null,"createdBy":"SHUJIEH","dateCreated":"2016-07-01","modifiedBy":"SHUJIEH","dateModified":"2016-07-05","changeNote":"PBTC-048","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5386298","version":"1","preferredName":"Brain MRI Tumor Measurement Serial Number","preferredDefinition":"The serial number of brain MRI that is used to measure the tumor size.  An organ composed of grey and white matter containing billions of neurons that is the center for intelligence and reasoning. It is protected by the bony cranium._Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide amazingly clear and detailed pictures of internal organs and tissues. The technique is valuable for the diagnosis of many pathologic conditions, including cancer, heart and vascular disease, stroke, and joint and musculoskeletal disorders._The measurement of the size of a tumor mass either clinically or in a surgically resected specimen._A unique identifier assigned to a member of a series of similar items._a free text field to specify information on the evaluations of the patient and the patient's disease","longName":"5376554v1.0:2018321v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"39931E17-3270-ABE8-E050-BB89AD43493E","latestVersionIndicator":"Yes","beginDate":"2016-08-08","endDate":null,"createdBy":"SHUJIEH","dateCreated":"2016-08-08","modifiedBy":"RICHARDS","dateModified":"2020-04-15","changeNote":"PBTC-048 Updated Preferred Question text following NIC guidance sr 101816","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5386703","version":"1","preferredName":"Brain MRI Tumor Measurement Image Number","preferredDefinition":"The brain MRI image number that is used to measure tumor size.  An organ composed of grey and white matter containing billions of neurons that is the center for intelligence and reasoning. It is protected by the bony cranium._Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide amazingly clear and detailed pictures of internal organs and tissues. The technique is valuable for the diagnosis of many pathologic conditions, including cancer, heart and vascular disease, stroke, and joint and musculoskeletal disorders._The measurement of the size of a tumor mass either clinically or in a surgically resected specimen._Any record of an imaging event whether physical or electronic._A numeral or string of numerals expressing value, quantity, or identification._Any record of an imaging event whether physical or electronic._a free text field to specify information on the evaluations of the patient and the patient's disease","longName":"5386633v1.0:2018321v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"39955795-2F7A-7C5B-E050-BB89AD437867","latestVersionIndicator":"Yes","beginDate":"2016-08-08","endDate":null,"createdBy":"SHUJIEH","dateCreated":"2016-08-08","modifiedBy":"RICHARDS","dateModified":"2020-04-15","changeNote":"PBTC-048","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5389037","version":"1","preferredName":"Device Limited Toxicity Yes No Text Code Indicator","preferredDefinition":"An object contrived for a specific purpose._Restricted or in amount, size, or extent.:The finding of bodily harm due to the poisonous effects of something._Response of Y (Yes) or N (No) to a question.","longName":"5389026v1.0:2017337v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"39A67321-ABE3-DC55-E050-BB89AD436C68","latestVersionIndicator":"Yes","beginDate":"2016-08-09","endDate":null,"createdBy":"SHUJIEH","dateCreated":"2016-08-09","modifiedBy":"KUMMEROA","dateModified":"2023-07-20","changeNote":"PBTC-048","administrativeNotes":"2023.7.20 Updated def for 'No Value Exists'. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5390104","version":"1","preferredName":"Device Name","preferredDefinition":"The name of the study device.  One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing._An object contrived for a specific purpose.","longName":"Device_NAME","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":"ADEERS:NCI/CTEP Adverse Event Expedited Report System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"39A7957E-8826-42D8-E050-BB89AD431949","latestVersionIndicator":"Yes","beginDate":"2016-08-09","endDate":null,"createdBy":"SHUJIEH","dateCreated":"2016-08-09","modifiedBy":"SHUJIEH","dateModified":"2016-08-09","changeNote":"PBTC-048","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5395311","version":"1","preferredName":"Device Comment java.lang.String","preferredDefinition":"A written explanation, observation or criticism about the device usage.","longName":"5395296v1.0:2178533v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"39A9D8D4-A751-0DDB-E050-BB89AD4370F3","latestVersionIndicator":"Yes","beginDate":"2016-08-09","endDate":null,"createdBy":"SHUJIEH","dateCreated":"2016-08-09","modifiedBy":"SHUJIEH","dateModified":"2016-08-09","changeNote":"PBTC-048","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5407613","version":"1","preferredName":"Patient-Reported Outcomes Measurement Information System Measures Yes No Not Applicable Indicator","preferredDefinition":"The measurement of quality of life of patient, parent or proxy by PROMIS questionnaires.   A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary._Psychometrically validated measures designed for precise and efficient self-report measurement of physical, mental, and social health across chronic conditions. Items can be administered in static (short-form) or dynamic form (as computer adaptive tests)._The preferred Value Domain to indicate a question with permissible values of yes/no/not applicable.","longName":"5407594v1.0:3506036v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3A2027A1-BA15-984D-E050-BB89AD430EF3","latestVersionIndicator":"Yes","beginDate":"2016-08-15","endDate":null,"createdBy":"SHUJIEH","dateCreated":"2016-08-15","modifiedBy":"SHUJIEH","dateModified":"2016-09-09","changeNote":"PBTC-048","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5408161","version":"1","preferredName":"Patient Neurological Deficit or Dysfunction Quality-of-Life Assessment Yes No Not Applicable Indicator","preferredDefinition":"The measurement of patient Quality of Life using Neuro_QoL Questionnaire. A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary._A finding of pathologic function within the central or peripheral nervous system, secondary to developmental abnormalities, infections, neurologic damage, or tumors._A determination of an individual's sense of well-being and ability to enjoy life._The preferred Value Domain to indicate a question with permissible values of yes/no/not applicable.","longName":"5408158v1.0:3506036v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3A239264-55C6-D334-E050-BB89AD437D7B","latestVersionIndicator":"Yes","beginDate":"2016-08-15","endDate":null,"createdBy":"SHUJIEH","dateCreated":"2016-08-15","modifiedBy":"SBREXT","dateModified":"2016-09-15","changeNote":"PBTC-048","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5408213","version":"1","preferredName":"Parent Off Treatment Survey Yes No Indicator","preferredDefinition":"The survey for parent when the pediatric patient is off treatment. A mother or a father; an immediate progenitor._When a patient is not receiving therapy they are considered off treatment.  In clinical trials, a dosing schedule may require a patient to stop medication for a period of time, then resume, such as 28 days on and 7 days off._A document used in a method of data collection that involves interviewing (or giving questionnaires to) a representative and often large group of people._The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"5408193v1.0:3506068v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3A23FD6C-BF5C-1343-E050-BB89AD43053F","latestVersionIndicator":"Yes","beginDate":"2016-08-15","endDate":null,"createdBy":"SHUJIEH","dateCreated":"2016-08-15","modifiedBy":"SHUJIEH","dateModified":"2016-09-09","changeNote":"PBTC-048","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5427991","version":"1","preferredName":"Average Device Usage Per Day in Hours","preferredDefinition":"the duration of average device usage per day in hours","longName":"5427956v1.0:5427971v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3AAE1185-AFC7-64AA-E050-BB89AD432C26","latestVersionIndicator":"Yes","beginDate":"2016-08-22","endDate":null,"createdBy":"SHUJIEH","dateCreated":"2016-08-22","modifiedBy":"SHUJIEH","dateModified":"2016-08-29","changeNote":"PBTC-048","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5428331","version":"1","preferredName":"Overall Patient Compliance Device Usage Percentage Value","preferredDefinition":"The percentage value reflects the overall patient compliance of device usage.","longName":"5428013v1.0:5426343v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3AB0D172-108C-6B8B-E050-BB89AD43195F","latestVersionIndicator":"Yes","beginDate":"2016-08-22","endDate":null,"createdBy":"SHUJIEH","dateCreated":"2016-08-22","modifiedBy":"SHUJIEH","dateModified":"2016-08-29","changeNote":"PBTC-048","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5428351","version":"1","preferredName":"Patient Device Usage Compliance Yes No Indicator","preferredDefinition":"The Yes No indicator reflects whether the patient is compliant with the protocol defined device usage.","longName":"5428334v1.0:3506068v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3AB0D172-10AC-6B8B-E050-BB89AD43195F","latestVersionIndicator":"Yes","beginDate":"2016-08-22","endDate":null,"createdBy":"SHUJIEH","dateCreated":"2016-08-22","modifiedBy":"RICHARDS","dateModified":"2022-03-28","changeNote":"PBTC-048","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5458894","version":"1","preferredName":"Device Adverse Event Report Submission Date","preferredDefinition":"the date of device adverse experience report submission within 24 hours of the event.","longName":"5458893v1.0:2018550v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3C575C36-68B6-6810-E050-BB89AD434F7F","latestVersionIndicator":"Yes","beginDate":"2016-09-12","endDate":null,"createdBy":"SHUJIEH","dateCreated":"2016-09-12","modifiedBy":"SHUJIEH","dateModified":"2016-09-12","changeNote":"048","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5475041","version":"1","preferredName":"Patient Questionnaire Complete Event Day Name","preferredDefinition":"The day of a course when the patient completes the survey","longName":"2194332v1.0:5152991v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3CF791C9-F1DE-6BB9-E053-F662850A714A","latestVersionIndicator":"Yes","beginDate":"2016-09-20","endDate":null,"createdBy":"RICHARDS","dateCreated":"2016-09-20","modifiedBy":"RICHARDS","dateModified":"2016-09-21","changeNote":"048 slr092016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5527784","version":"1","preferredName":"Brain Neoplasm Transverse Plane Tumor Dimension Measurement","preferredDefinition":"Brain Tumor Transverse measurement (cm)","longName":"TR Measurement (cm)","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3F3DB10D-60C0-17AF-E053-F662850A164E","latestVersionIndicator":"Yes","beginDate":"2016-10-19","endDate":null,"createdBy":"RICHARDS","dateCreated":"2016-10-19","modifiedBy":"RICHARDS","dateModified":"2016-10-20","changeNote":"PBTC 101916 sr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5527789","version":"2","preferredName":"Brain Neoplasm Anterior Posterior Plane Tumor Dimension Measurement","preferredDefinition":"Brain Tumor AP Measurement (cm)","longName":"AP Measurement (cm)","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3FDD94D1-76B1-79E6-E053-F662850A31CE","latestVersionIndicator":"Yes","beginDate":"2016-10-27","endDate":null,"createdBy":"RICHARDS","dateCreated":"2016-10-27","modifiedBy":"RICHARDS","dateModified":"2016-10-27","changeNote":"PBTC 101916 sr slr 102716 updated with revised DEC to capture Anterior/Posterior concept","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5527988","version":"1","preferredName":"Brain Neoplasm Superoinferior Plane Tumor Dimension Measurement","preferredDefinition":"Brain Tumor Superoinferior measurement (cm)","longName":"SI Measurement (cm)","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3F4E6A76-668E-4228-E053-F662850A9585","latestVersionIndicator":"Yes","beginDate":"2016-10-20","endDate":null,"createdBy":"RICHARDS","dateCreated":"2016-10-20","modifiedBy":"RICHARDS","dateModified":"2016-10-20","changeNote":"102016 slr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5543565","version":"1","preferredName":"Patient Cerebrospinal Fluid Cytology Yes No Not Applicable Indicator","preferredDefinition":"The yes/ no/ NA indicator related to the tumor dissemination in CSF, which is necessary to allow a patient to participate in a clinical study.","longName":"5543527v1.0:3506036v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3FB74E72-F791-6A3B-E053-F662850A4B33","latestVersionIndicator":"Yes","beginDate":"2016-10-25","endDate":null,"createdBy":"SHUJIEH","dateCreated":"2016-10-25","modifiedBy":"SHUJIEH","dateModified":"2016-10-26","changeNote":"048","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5543830","version":"1","preferredName":"Child Age Yes No Indicator","preferredDefinition":"the yes no indicator that asks about the child age.","longName":"5543829v1.0:3506068v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3FC7AE76-04DF-4A52-E053-F662850A933D","latestVersionIndicator":"Yes","beginDate":"2016-10-26","endDate":null,"createdBy":"SHUJIEH","dateCreated":"2016-10-26","modifiedBy":"SHUJIEH","dateModified":"2018-02-07","changeNote":"048","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5580948","version":"2","preferredName":"Clinical Study Protocol Stratification Factors Protocol Stratification Factors Type","preferredDefinition":"information related to the protocol stratification factors._The protocol stratum on which a subject is assigned","longName":"Assigned Stratum","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4442D9A2-C76F-2C25-E053-F662850ABF70","latestVersionIndicator":"Yes","beginDate":"2016-12-22","endDate":null,"createdBy":"RICHARDS","dateCreated":"2016-12-22","modifiedBy":"RICHARDS","dateModified":"2018-02-19","changeNote":"slr 122216.  Added PVs 030617","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5586770","version":"1","preferredName":"Neoplasm Mutation Abnormality Increase Burden Assessment Indicator","preferredDefinition":"The response that indicates whether a person has an increased tumor mutation burden","longName":"Inc_Tumor Burden","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"429F9451-D8D0-6969-E053-F662850AFED7","latestVersionIndicator":"Yes","beginDate":"2016-12-01","endDate":null,"createdBy":"RICHARDS","dateCreated":"2016-12-01","modifiedBy":"RICHARDS","dateModified":"2016-12-15","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5589293","version":"1","preferredName":"Neoplasm Mutation Abnormality Technique Type","preferredDefinition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer._A practiced and regimented skill or series of actions._Something distinguishable as an identifiable class based on common qualities.","longName":"TMB_Technique","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42EE4D63-F2E9-54BA-E053-F662850A74AA","latestVersionIndicator":"Yes","beginDate":"2016-12-05","endDate":null,"createdBy":"RICHARDS","dateCreated":"2016-12-05","modifiedBy":"RICHARDS","dateModified":"2018-02-08","changeNote":"PBTC slr 120516","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5596099","version":"1","preferredName":"Concomitant Neoplasm Associated Constitutional Mismatch Repair Deficiency Syndrome Indicator","preferredDefinition":"The response that indicates whether a person has other concomitant tumors associated with CMMRD syndrome","longName":"CMMRD_Associated_Tumor","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"43152066-4D1A-650F-E053-F662850A59E3","latestVersionIndicator":"Yes","beginDate":"2016-12-07","endDate":null,"createdBy":"RICHARDS","dateCreated":"2016-12-07","modifiedBy":"RICHARDS","dateModified":"2016-12-15","changeNote":"PBTC slr 120716","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5794584","version":"1","preferredName":"Clinical IndicationSurgical Procedure Amenable Indicator","preferredDefinition":"Relating to a patients suitability to undergo a clinically indicated surgical procedure","longName":"CLIN_IND_SURG_PRO_AMEN_IND","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4E3D003F-F0DB-1024-E053-F662850A35CC","latestVersionIndicator":"Yes","beginDate":"2017-04-28","endDate":null,"createdBy":"RICHARDS","dateCreated":"2017-04-28","modifiedBy":"RICHARDS","dateModified":"2020-04-01","changeNote":"PBTC-050 042817 slr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5806488","version":"1","preferredName":"Retinoblastoma-Associated Protein Neoplasm Positive Negative Not Applicable Category","preferredDefinition":"The response that indicates whether a tumor specimen is Rb1 Positive or negative","longName":"Rb1_Pos_Neg_NA_Results","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4EA65B35-6466-4A69-E053-F662850A7C80","latestVersionIndicator":"Yes","beginDate":"2017-05-03","endDate":null,"createdBy":"RICHARDS","dateCreated":"2017-05-03","modifiedBy":"RICHARDS","dateModified":"2017-05-09","changeNote":"PBTC-050 050317 slr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5811382","version":"1","preferredName":"Tissue Specimen Condition Description Text","preferredDefinition":"Description of the condition of a tissue sample at the time of submission","longName":"Tiss_Spec_Cond_Desc_Text","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F2F4281-A982-6B60-E053-F662850AA83B","latestVersionIndicator":"Yes","beginDate":"2017-05-10","endDate":null,"createdBy":"RICHARDS","dateCreated":"2017-05-10","modifiedBy":"RICHARDS","dateModified":"2017-05-10","changeNote":"PBTC 050 slr 051017","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5813059","version":"1","preferredName":"Patient Myelosuppressive Chemotherapy Biological Agent Monoclonal Ab RT Recovered or Resolved Clinical Trial Eligibility Criteria Yes No Indicator","preferredDefinition":"A yes/no indicator related to if the adverse events associated with prior therapy (myelosuppressive chemotherapy, biological agent, monoclonal antibody, radiation therapy) have recovered, which are necessary to allow a patient to participate in a clinical study.","longName":"5813058v1.0:3506068v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F311F22-2ABE-0CAC-E053-F662850AA29A","latestVersionIndicator":"Yes","beginDate":"2017-05-10","endDate":null,"createdBy":"SHUJIEH","dateCreated":"2017-05-10","modifiedBy":"SHUJIEH","dateModified":"2017-05-10","changeNote":"051","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5813284","version":"1","preferredName":"Specimen Collection pre Surgical Procedure Period Frequency","preferredDefinition":"The response that indicates the time point a specimen was collected prior to surgery.","longName":"Spec_Coll_Surg_Period_Freq","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F31A4C5-01C4-211E-E053-F662850AEE7F","latestVersionIndicator":"Yes","beginDate":"2017-05-10","endDate":null,"createdBy":"RICHARDS","dateCreated":"2017-05-10","modifiedBy":"RICHARDS","dateModified":"2017-05-10","changeNote":"PBTC slr 051017","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5813957","version":"1","preferredName":"Patient Autologous BMT Autologous HSCT CD4 Count Clinical Trial Eligibility Criteria Yes No Not Applicable Indicator","preferredDefinition":"the yes, no, not applicable indicator to specify if the patient received autologous bone marrow or stem cell transplant prior to study entry, and the CD4 expressing cell count.","longName":"5813935v1.0:3506036v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F320A13-83F6-3844-E053-F662850A7A62","latestVersionIndicator":"Yes","beginDate":"2017-05-10","endDate":null,"createdBy":"SHUJIEH","dateCreated":"2017-05-10","modifiedBy":"SHUJIEH","dateModified":"2017-05-10","changeNote":"051","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5822342","version":"1","preferredName":"Patient Coagulation Disorder Bleeding Diathesis Anticoagulant Agent Clinical Trial Eligibility Criteria Yes No Indicator","preferredDefinition":"The yes/no indicator related to the patient's eligibility to participate in a study regarding coagulopathy, bleeding diathesis, or the use of systemic anticoagulant medication.","longName":"5822341v1.0:3506068v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F324A6E-6B24-25CE-E053-F662850AFC03","latestVersionIndicator":"Yes","beginDate":"2017-05-11","endDate":null,"createdBy":"SHUJIEH","dateCreated":"2017-05-11","modifiedBy":"SHUJIEH","dateModified":"2017-05-11","changeNote":"051","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5822649","version":"1","preferredName":"Patient Allogeneic Hematopoietic Stem Cell Transplantation Clinical Trial Eligibility Criteria Yes No Indicator","preferredDefinition":"a yes/no indicator related to the patient's eligibility to participate in a study regarding whether a patient has received allogeneic hematopoietic stem cell transplantation.","longName":"5822598v1.0:3506068v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F42A845-62DC-0F85-E053-F662850A85AB","latestVersionIndicator":"Yes","beginDate":"2017-05-11","endDate":null,"createdBy":"SHUJIEH","dateCreated":"2017-05-11","modifiedBy":"SHUJIEH","dateModified":"2017-05-11","changeNote":"051","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"5828038","version":"1","preferredName":"Informed Consent Disease Screening Signature Indicator","preferredDefinition":"The response which indicates whether a person has signed the screening consent","longName":"IC_Screening_ Sign_Ind","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4FA9FCB4-4931-5862-E053-F662850AC29A","latestVersionIndicator":"Yes","beginDate":"2017-05-16","endDate":null,"createdBy":"RICHARDS","dateCreated":"2017-05-16","modifiedBy":"RICHARDS","dateModified":"2019-09-13","changeNote":"PBTC slr 051617","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6053545","version":"1","preferredName":"Patient Minor Surgical Procedure Clinical Trial Eligibility Criteria Yes No Not Applicable Indicator","preferredDefinition":"The yes/no/not applicable question as to whether a person's last time of minor surgery is acceptable based on eligibility criteria with permissible values of yes/no/not applicable.","longName":"Elig_MinSurg","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"63286676-2563-7297-E053-F662850AD649","latestVersionIndicator":"Yes","beginDate":"2018-01-19","endDate":null,"createdBy":"RICHARDS","dateCreated":"2018-01-19","modifiedBy":"ZHWENDY","dateModified":"2023-02-20","changeNote":null,"administrativeNotes":"1/20/2023: Added AQT per cadsr0002069.wz","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6053547","version":"1","preferredName":"Patient Bulk Neoplasm Definition Clinical Study Protocol Clinical Trial Eligibility Criteria Yes No Not Applicable Indicator","preferredDefinition":"The yes/no/not applicable question as to whether a person has bulky disease based on eligibility criteria definition with permissible values of yes/no/not applicable.","longName":"Bulky_DiseaseYNNA","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6329456D-9164-5A4E-E053-F662850A04D4","latestVersionIndicator":"Yes","beginDate":"2018-01-19","endDate":null,"createdBy":"RICHARDS","dateCreated":"2018-01-19","modifiedBy":"RICHARDS","dateModified":"2018-02-08","changeNote":"PBTC 19Jan2017 slr to update PVs","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6072639","version":"1","preferredName":"Knee Joint X-Ray Physical Examination Date","preferredDefinition":"The date on which a knee X-ray was examined.","longName":"6072633v1.0:2018550v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"65462695-7A5E-7809-E053-F662850A0C8A","latestVersionIndicator":"Yes","beginDate":"2018-02-15","endDate":null,"createdBy":"SHUJIEH","dateCreated":"2018-02-15","modifiedBy":"SHUJIEH","dateModified":"2018-02-15","changeNote":"PBTC-049","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6072640","version":"1","preferredName":"Knee Joint X-Ray Status","preferredDefinition":"A condition at a particular time of a medical imaging (knee X-ray) procedure.","longName":"6072633v1.0:2555215v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"65444760-EFD1-2BC8-E053-F662850A231F","latestVersionIndicator":"Yes","beginDate":"2018-02-15","endDate":null,"createdBy":"SHUJIEH","dateCreated":"2018-02-15","modifiedBy":"SHUJIEH","dateModified":"2018-02-15","changeNote":"PBTC-049","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6072653","version":"1","preferredName":"Knee Joint Magnetic Resonance Imaging Date","preferredDefinition":"The date on which a knee MRI was examined.","longName":"6072652v1.0:2018550v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6546F5D3-DFA4-0631-E053-F662850AD37A","latestVersionIndicator":"Yes","beginDate":"2018-02-15","endDate":null,"createdBy":"SHUJIEH","dateCreated":"2018-02-15","modifiedBy":"SHUJIEH","dateModified":"2018-02-15","changeNote":"PBTC-049","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6072654","version":"1","preferredName":"Knee Joint Magnetic Resonance Imaging Status","preferredDefinition":"A condition or state at a particular time of knee MRI.","longName":"6072652v1.0:2555215v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"65472CC7-129E-43C8-E053-F662850A7410","latestVersionIndicator":"Yes","beginDate":"2018-02-15","endDate":null,"createdBy":"SHUJIEH","dateCreated":"2018-02-15","modifiedBy":"SHUJIEH","dateModified":"2018-02-15","changeNote":"PBTC-049","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6077926","version":"1","preferredName":"Radiation Therapy Prior Administered Yes No Not Applicable Indicator","preferredDefinition":"The yes/no/NA indicator related to if patient has had prior radiation therapy.","longName":"6077925v1.0:3506036v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"65C12DC8-06B6-3A17-E053-F662850A5B1B","latestVersionIndicator":"Yes","beginDate":"2018-02-21","endDate":null,"createdBy":"SHUJIEH","dateCreated":"2018-02-21","modifiedBy":"BOWSERC","dateModified":"2021-12-09","changeNote":"PBTC-049","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6077929","version":"1","preferredName":"Prior Allogeneic Hematopoietic Stem Cell Transplantation Administered Yes No Not Applicable Indicator","preferredDefinition":"Indicator of Yes or No or NA to signify that an individual has received a prior allogeneic stem cell transplant.","longName":"6077928v1.0:3506036v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"65C11B85-4599-428D-E053-F662850A91CB","latestVersionIndicator":"Yes","beginDate":"2018-02-21","endDate":null,"createdBy":"SHUJIEH","dateCreated":"2018-02-21","modifiedBy":"MORENOC","dateModified":"2018-08-13","changeNote":"PBTC-049","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6077933","version":"1","preferredName":"Prior Autologous Hematopoietic Stem Cell Transplantation Administered Yes No Not Applicable Indicator","preferredDefinition":"Indicator of Yes or No or NA to signify that an individual has received a prior autologous stem cell transplant.","longName":"6077932v1.0:3506036v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"65C22699-D77C-1FD5-E053-F662850ACE52","latestVersionIndicator":"Yes","beginDate":"2018-02-21","endDate":null,"createdBy":"SHUJIEH","dateCreated":"2018-02-21","modifiedBy":"SHUJIEH","dateModified":"2018-02-21","changeNote":"PBTC-049","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6133615","version":"1","preferredName":"Patient Central Nervous System Disease or Disorder Eligibility Determination Yes No Unknown Not Applicable Indicator","preferredDefinition":"The information (yes/no/unknown/not applicable) related to eligibility criteria for person who receives medical attention, care, or treatment having disease related to the brain and spinal cord.","longName":"2974446v1.0:3506035v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":"GOG CRF:Gynecologic Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6766DA12-D226-3903-E053-F662850A520C","latestVersionIndicator":"Yes","beginDate":"2018-03-14","endDate":null,"createdBy":"SHUJIEH","dateCreated":"2018-03-14","modifiedBy":"BOWSERC","dateModified":"2021-06-22","changeNote":"PBTC-049","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6290505","version":"1","preferredName":"Person Thromboembolism Medical History Yes No Unknown Not Applicable Indicator","preferredDefinition":"The yes/no/unknown/not applicable question relating to a record of a patient's background regarding an obstruction of a vessel by a blood clot that has been transported from a distant site by the blood stream.","longName":"2429850v1.0:3506035v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6C57BAB0-A2C6-4699-E053-F662850A47A4","latestVersionIndicator":"Yes","beginDate":"2018-05-16","endDate":null,"createdBy":"SHUJIEH","dateCreated":"2018-05-16","modifiedBy":"SHUJIEH","dateModified":"2018-05-23","changeNote":"PBTC-049","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6352059","version":"1","preferredName":"Knee Joint Magnetic Resonance Imaging Status","preferredDefinition":"A condition or state at a particular time of knee MRI imaging.","longName":"6072650v1.0:2261670v1.0_Imagin","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"70BEAD0A-196B-2AAB-E053-F662850A1615","latestVersionIndicator":"Yes","beginDate":"2018-07-11","endDate":null,"createdBy":"SHUJIEH","dateCreated":"2018-07-11","modifiedBy":"SHUJIEH","dateModified":"2018-07-11","changeNote":"PBTC-049","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6352093","version":"1","preferredName":"Knee Joint X-Ray Exam Status","preferredDefinition":"A condition or state at a particular time of knee X-ray imaging.","longName":"6072631v1.0:2261670v1.0_Imagin","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"70BF4315-40C0-25B2-E053-F662850A9E6B","latestVersionIndicator":"Yes","beginDate":"2018-07-11","endDate":null,"createdBy":"SHUJIEH","dateCreated":"2018-07-11","modifiedBy":"SHUJIEH","dateModified":"2018-07-11","changeNote":"PBTC-049","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6409341","version":"1","preferredName":"Person Correctional Institution Exclusion Criteria Assessment Results Indicator","preferredDefinition":"A yes/no/unknown/not available/not applicable indicator related to prisoner.","longName":"6409329v1.0:2713491v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"740E345B-C585-34A6-E053-F662850A0A0D","latestVersionIndicator":"Yes","beginDate":"2018-08-22","endDate":null,"createdBy":"SHUJIEH","dateCreated":"2018-08-22","modifiedBy":"SHUJIEH","dateModified":"2018-08-22","changeNote":"PBTC-049","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6422727","version":"1","preferredName":"Fixed Tissue Paraffin Blocks Mutation Abnormality Indicator","preferredDefinition":"Text indicator to signify whether mutation is identified in tumor tissues.","longName":"3123691v1.0:6422721v1.0","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7496B228-EB6B-52F9-E053-F662850AA5C7","latestVersionIndicator":"Yes","beginDate":"2018-08-29","endDate":null,"createdBy":"SHUJIEH","dateCreated":"2018-08-29","modifiedBy":"RICHARDS","dateModified":"2022-03-24","changeNote":"Curated for PBTC-049","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6444882","version":"1","preferredName":"Malignant Neoplasm Remission Exclusion Eligibility Determination Yes No Not Applicable Indicator","preferredDefinition":"The yes/no indicator related to eligibility based on malignancies that are in remission.","longName":"Remission_Status_Ind","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76C9F568-A2A8-2E22-E053-F662850A228A","latestVersionIndicator":"Yes","beginDate":"2018-09-26","endDate":null,"createdBy":"RICHARDS","dateCreated":"2018-09-26","modifiedBy":"ZHWENDY","dateModified":"2022-08-02","changeNote":"PBTC slr 092618","administrativeNotes":"8/2/2022: fixed the box symbol in AQT_wz","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6454131","version":"1","preferredName":"Off Treatment Primary Associated Adverse Event Common Terminology Criteria for Adverse Events Version 5 Term Name","preferredDefinition":"The response that indicates the CTCAE v5.0 Primary AE term associated with the Off Treatment Reason","longName":"Off_Tx_Primary_AE_Term","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7733DFF9-772C-750B-E053-F662850A8139","latestVersionIndicator":"Yes","beginDate":"2018-10-01","endDate":null,"createdBy":"RICHARDS","dateCreated":"2018-10-01","modifiedBy":"RICHARDS","dateModified":"2018-10-02","changeNote":"slr 100118","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6572204","version":"1","preferredName":"Patient Pharmacologic Substance Prior Surgical Procedure Clinical Trial Eligibility Criteria Yes No Not Applicable Indicator","preferredDefinition":"The response that indicates the patient's willingness to take a study agent prior to surgery.","longName":"PT_Rx_Prior_Surgery_Elig","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BD0FD54-8735-14AE-E053-F662850ACBFB","latestVersionIndicator":"Yes","beginDate":"2018-11-29","endDate":null,"createdBy":"RICHARDS","dateCreated":"2018-11-29","modifiedBy":"RICHARDS","dateModified":"2018-11-29","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6577295","version":"1","preferredName":"Bone Age X-Ray Assessment Date","preferredDefinition":"The response that indicates the date of the Bone Age X-ray Assessment","longName":"Bone_Age_XR_Date","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C387C21-8636-1EFA-E053-F662850A7472","latestVersionIndicator":"Yes","beginDate":"2018-12-04","endDate":null,"createdBy":"RICHARDS","dateCreated":"2018-12-04","modifiedBy":"RICHARDS","dateModified":"2018-12-04","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6577323","version":"1","preferredName":"Patient Age Month Value","preferredDefinition":"The response that indicates the patient's chronological age in months","longName":"PT_Age_Mos","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C479E96-970D-204B-E053-F662850A0701","latestVersionIndicator":"Yes","beginDate":"2018-12-05","endDate":null,"createdBy":"RICHARDS","dateCreated":"2018-12-05","modifiedBy":"RICHARDS","dateModified":"2018-12-05","changeNote":"PBTC slr 120518","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6577389","version":"1","preferredName":"X-Ray Standard Deviation Bone age Month Value","preferredDefinition":"The result that indicates the standard deviation for the Bone Age result in months","longName":"Bone_Age_SD_Mos","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C4AE57C-F21C-55DE-E053-F662850AB39C","latestVersionIndicator":"Yes","beginDate":"2018-12-05","endDate":null,"createdBy":"RICHARDS","dateCreated":"2018-12-05","modifiedBy":"RICHARDS","dateModified":"2018-12-12","changeNote":"PBTC Slr 120518","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6577870","version":"1","preferredName":"Reviewer Bone Growth Assessment Growth Assessment Indicator","preferredDefinition":"The result that indicates the impression of the reviewer regarding growth assessment","longName":"Reviewer_Bone_Growth_IND","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C4AA136-0AEE-4501-E053-F662850A136E","latestVersionIndicator":"Yes","beginDate":"2018-12-05","endDate":null,"createdBy":"RICHARDS","dateCreated":"2018-12-05","modifiedBy":"RICHARDS","dateModified":"2018-12-05","changeNote":"PBTC slr 120518","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6581916","version":"1","preferredName":"Patient Skeletal System Mature Assessment Type","preferredDefinition":"The response that indicates whether a person is skeletally-mature or skeletally immature based on bone age assessment","longName":"PT_Skeletal_Mature_Type","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C60696F-B735-66F0-E053-F662850A64D4","latestVersionIndicator":"Yes","beginDate":"2018-12-06","endDate":null,"createdBy":"RICHARDS","dateCreated":"2018-12-06","modifiedBy":"RICHARDS","dateModified":"2018-12-06","changeNote":"PBTC slr 120618","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6816088","version":"1","preferredName":"BRAF Gene Cytogenetic Abnormality Identification Type","preferredDefinition":"The response that indicates the type of BRAF aberration identified by genetic analysis","longName":"BRAF_Aberration_Type","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D5C18E7-03E8-5239-E053-F662850A910C","latestVersionIndicator":"Yes","beginDate":"2019-07-10","endDate":null,"createdBy":"RICHARDS","dateCreated":"2019-07-10","modifiedBy":"RICHARDS","dateModified":"2019-07-10","changeNote":"PBTC 071019 slr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6817150","version":"1","preferredName":"10-2 Visual Field Testing Assessment Normal Abnormal Not Obtained Indicator","preferredDefinition":"The response that indicates if the visual field assessment that tests the central 10 degrees, creating 68 points with 2 degrees between points is normal or abnormal or not obtained. It is most often used on patients with conditions that affect central vision (e.g., macular degeneration, diabetic retinopathy) or when only a small amount of central vision remains (e.g., end-stage glaucoma).","longName":"10-2_Visual_Field","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D7E6DFA-778F-5A27-E053-F662850A6964","latestVersionIndicator":"Yes","beginDate":"2019-07-12","endDate":null,"createdBy":"RICHARDS","dateCreated":"2019-07-12","modifiedBy":"RICHARDS","dateModified":"2019-07-12","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6817151","version":"1","preferredName":"Spectral Domain Optical Coherence Tomography Assessment Normal Abnormal Not Obtained Indicator","preferredDefinition":"The response that indicates a modification of optical coherence tomography with an increased ability to provide depth-resolved tissue structure information. It is used to perform high-resolution cross-sectional imaging and analysis of structural changes in the eye during disease progression.","longName":"SD-OCT_Assessment","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D7CB114-6A43-0C40-E053-F662850A2C12","latestVersionIndicator":"Yes","beginDate":"2019-07-12","endDate":null,"createdBy":"RICHARDS","dateCreated":"2019-07-12","modifiedBy":"RICHARDS","dateModified":"2019-07-12","changeNote":"PBTC slr 071219","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6817175","version":"1","preferredName":"Fundus Autofluorescence Imaging Assessment Normal Abnormal Not Obtained Indicator","preferredDefinition":"A response that indicates the results of a retinal imaging test that maps the presence of lipofuscin in the retina pigment epithelium.","longName":"FAF_Assessment","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D7CA1CB-2740-0C30-E053-F662850A17D5","latestVersionIndicator":"Yes","beginDate":"2019-07-12","endDate":null,"createdBy":"RICHARDS","dateCreated":"2019-07-12","modifiedBy":"RICHARDS","dateModified":"2019-07-12","changeNote":"PBTC slr 071219","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6817179","version":"1","preferredName":"Patient Prisoners Or Compulsory  Participation Yes No Not Applicable Indicator","preferredDefinition":"A response to indicate whether a person who receives medical attention, care, or treatment who is a correctional institution resident","longName":"PT_Prisoner","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D7D6859-9EAC-5A23-E053-F662850A116A","latestVersionIndicator":"Yes","beginDate":"2019-07-12","endDate":null,"createdBy":"RICHARDS","dateCreated":"2019-07-12","modifiedBy":"RICHARDS","dateModified":"2019-07-12","changeNote":"071219 created for PBTC eligibility","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"6817188","version":"1","preferredName":"Intervention or Procedure Negation Discontinue Occurrence Clinical Trial Eligibility Criteria Yes No Not Applicable Indicator","preferredDefinition":"A response that indicates whether the patient is able to discontinue prohibited medications to meet clinical trial eligibility.","longName":"Pt_Discontinue_ConMed","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D7D5B63-DEA1-362E-E053-F662850AD5FB","latestVersionIndicator":"Yes","beginDate":"2019-07-12","endDate":null,"createdBy":"RICHARDS","dateCreated":"2019-07-12","modifiedBy":"KUMMEROA","dateModified":"2022-07-12","changeNote":"7/12/19 for PBTC Eligibility","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7238946","version":"1","preferredName":"FDG-Positron Emission Tomography Avidity Lesion Quantity Number","preferredDefinition":"Enter the  number of the patient's FDG avid lesions.","longName":"Lesion Number","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A254CE91-9128-6B4F-E053-F662850AAE3C","latestVersionIndicator":"Yes","beginDate":"2020-04-02","endDate":null,"createdBy":"RICHARDS","dateCreated":"2020-04-02","modifiedBy":"HARTLEYG","dateModified":"2020-06-10","changeNote":"PBTC 040220 slr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7331858","version":"1","preferredName":"Research Biospecimen Collection Schedule Schedule Interval","preferredDefinition":"Systematic investigation into a subject in order to discover facts, establish or revise a theory, or develop a plan of action based on the facts discovered._Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products._The act of gathering things together; having been brought together in one place._Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products._The act of gathering things together; having been brought together in one place._An ordered list of times at which things are planned to occur._An ordered list of schedules at which specimens are collected","longName":"Sample_Coll_Interval","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A82206F3-62C9-0931-E053-4EBD850A81DA","latestVersionIndicator":"Yes","beginDate":"2020-06-15","endDate":null,"createdBy":"RICHARDS","dateCreated":"2020-06-15","modifiedBy":"RICHARDS","dateModified":"2020-06-15","changeNote":"slr 061520","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7342933","version":"1","preferredName":"Eye Examination Assessment Result Normal Abnormal Indicator","preferredDefinition":"Outcome of an eye examination performed using another method of assessment","longName":"Eye_Exam_Other_ Result","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A8DAA523-228E-6A05-E053-4EBD850A6F5B","latestVersionIndicator":"Yes","beginDate":"2020-06-24","endDate":null,"createdBy":"RICHARDS","dateCreated":"2020-06-24","modifiedBy":"RICHARDS","dateModified":"2020-06-24","changeNote":"PBTC slr 062420","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7577421","version":"1","preferredName":"Agent Dose Calculation Method Dose Determination Method Type","preferredDefinition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect._A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time._The procedure or activity of determining something by mathematical or logical methods._A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal._Something distinguishable as an identifiable class based on common qualities.","longName":"Dose_Calc_Method","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB2512A6-F209-2E58-E053-4EBD850AC42D","latestVersionIndicator":"Yes","beginDate":"2021-02-12","endDate":null,"createdBy":"RICHARDS","dateCreated":"2021-02-12","modifiedBy":"RICHARDS","dateModified":"2021-02-19","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7591859","version":"3","preferredName":"Nervous System Domain Nuclear Medicine Cerebrospinal fluid flow imaging Diagnostic Procedure CDISC SDTM Method Terminology Type","preferredDefinition":"Result to indicate the method used complete a CSF Flow Imaging Diagnostic Procedure","longName":"NV_NVMETHOD_CSFFLOW","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C77FBA01-9725-3B36-E053-4EBD850AD87D","latestVersionIndicator":"Yes","beginDate":"2021-03-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-07-19","modifiedBy":"KUMMEROA","dateModified":"2021-07-27","changeNote":"2021-7-27 ak Released per QA.; 2021-7-19 ak Versioned due to newer VD updates for PKG 46.  2021-4-16 ak Versioned due to newer VD updates, OK'd by Shengcheng.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7591860","version":"1","preferredName":"Nervous System Domain Nuclear Medicine Cerebrospinal fluid flow imaging Diagnostic Procedure CDISC Variable Terminology Date","preferredDefinition":"The date a CSF Flow imaging study was completed","longName":"NV_NVDAT_CSFFLOW","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD202322-9249-612A-E053-4EBD850A2E2B","latestVersionIndicator":"Yes","beginDate":"2021-03-09","endDate":null,"createdBy":"RICHARDS","dateCreated":"2021-03-09","modifiedBy":"RICHARDS","dateModified":"2021-03-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7591861","version":"1","preferredName":"Nervous System Domain Nuclear Medicine Cerebrospinal fluid flow imaging Diagnostic Procedure CDISC SDTM Normal Abnormal Response Terminology Outcome","preferredDefinition":"The result reported for a CSF Flow imaging procedure","longName":"NV_NVORRES_CSFFLOW","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD1EB1D0-DD46-27ED-E053-4EBD850AC469","latestVersionIndicator":"Yes","beginDate":"2021-03-09","endDate":null,"createdBy":"RICHARDS","dateCreated":"2021-03-09","modifiedBy":"RICHARDS","dateModified":"2021-03-23","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7717137","version":"1","preferredName":"Optic Cup to Disc Ratio Finding Specify Text","preferredDefinition":"The ratio of the diameter of the optic cup compared to the diameter of the optic disc assessment result.","longName":"Optic CD Ratio_SPC_TXT","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C676F2BA-10F7-2DF5-E053-4EBD850A3D1D","latestVersionIndicator":"Yes","beginDate":"2021-07-06","endDate":null,"createdBy":"RICHARDS","dateCreated":"2021-07-06","modifiedBy":"RICHARDS","dateModified":"2021-07-06","changeNote":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7787699","version":"1","preferredName":"Findings About Events or Interventions Supplemental Qualifiers Dataset Qualifier Data Value Magnetic Resonance Imaging Anatomic Site","preferredDefinition":"A description of the anatomical location of the MRI scan.","longName":"SUPPFA_QVAL_MRILOC","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CC8F54EA-7BA8-3F43-E053-4EBD850A9367","latestVersionIndicator":"Yes","beginDate":"2021-09-22","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2021-09-22","modifiedBy":"KUMMEROA","dateModified":"2023-07-19","changeNote":null,"administrativeNotes":"2023.7.19 AQT/Alt SN added per ticket request CADSR0002626. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"7797495","version":"1","preferredName":"Therapeutic Cells Unit of Measure","preferredDefinition":"The unit of measure of the dosage level for therapeutic cells.","longName":"TX_CELLS_UOM","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CDD8E429-E7B9-29A0-E053-4EBD850A79FE","latestVersionIndicator":"Yes","beginDate":"2021-10-08","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2021-10-08","modifiedBy":"HARTLEYG","dateModified":"2021-10-08","changeNote":"Curated to support PBTC protocol_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"8148167","version":"1","preferredName":"Patient Central Nervous System Disease or Disorder Eligibility Determination Institutional Identifier","preferredDefinition":"The coded response indicating a patient meets the eligibility criteria for completion of disease subtyping at a protocol specified institutional laboratory.","longName":"Diag_SCR_Lab_Name","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":"GOG CRF:Gynecologic Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC0408C2-67DC-1263-E053-4EBD850AA336","latestVersionIndicator":"Yes","beginDate":"2022-04-06","endDate":null,"createdBy":"RICHARDS","dateCreated":"2022-04-06","modifiedBy":"RICHARDS","dateModified":"2022-04-07","changeNote":"Created study specific Value domain. SRichardson","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11479369","version":"1","preferredName":"Herpes Simplex Virus Quantitative Polymerase Chain Reaction Outcome 0 Decimal Place Copies per Milliliter Value","preferredDefinition":"The 0 decimal place numeric laboratory value measured, assigned or computed related to herpes simplex virus quantitative polymerase chain reaction outcome.","longName":"11479368v1.00:5038613v1.00","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EB54F412-A5B0-1751-E053-731AD00AAE64","latestVersionIndicator":"Yes","beginDate":"2022-10-18","endDate":null,"createdBy":"ZHWENDY","dateCreated":"2022-10-18","modifiedBy":"ZHWENDY","dateModified":"2023-06-02","changeNote":null,"administrativeNotes":"6/2/2023: reviewed and released per the metric report.wz","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"11480666","version":"1","preferredName":"Antibody Herpes Simplex Virus Test Laboratory Procedure Outcome Integer::2 Decimal Place Value","preferredDefinition":"The 2 decimal place numeric laboratory value measured, assigned or computed related to herpes simplex virus outcome.","longName":"2195796v1.00:2784513v1.00","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EB79002A-C3F6-7356-E053-731AD00A4363","latestVersionIndicator":"Yes","beginDate":"2022-10-20","endDate":null,"createdBy":"ZHWENDY","dateCreated":"2022-10-20","modifiedBy":"ZHWENDY","dateModified":"2023-06-02","changeNote":null,"administrativeNotes":"6/2/2023: reviewed and released per the metric report.wz","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12432550","version":"1","preferredName":"Procedure Supplemental Qualifiers Dataset Catheter Device Placement Fulfill Protocol Requirement Prior Infusion Procedure Yes No Indicator","preferredDefinition":"A Yes/No indicator to describe if the Catheter placement meet protocol requirements prior infusion.","longName":"SUPPPR_QVAL_PRCATHFPRREQ_IND","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F2F45F33-D9C4-2AF6-E053-731AD00A9671","latestVersionIndicator":"Yes","beginDate":"2023-01-23","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-01-23","modifiedBy":"ZHWENDY","dateModified":"2023-08-21","changeNote":null,"administrativeNotes":"1/23/2023-created CDE for PBTC-CADSR0001919-MM","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12432566","version":"1","preferredName":"Patient Participation Optional Screening Yes No Indicator","preferredDefinition":"The yes/no indicator for information related to a patient's participation in optional screening","longName":"OPT_SCRN_IND","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F2F58DEA-42C7-619D-E053-731AD00AFA08","latestVersionIndicator":"Yes","beginDate":"2023-01-23","endDate":null,"createdBy":"RAGUNATHANU","dateCreated":"2023-01-23","modifiedBy":"MMADDINENI","dateModified":"2023-06-02","changeNote":null,"administrativeNotes":"01/23/2023 created for PBTC_caDSR0001919_01152023 UR","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12432570","version":"1","preferredName":"Procedure Supplemental Qualifiers Dataset Infusion Procedure Catheter Device Use Count","preferredDefinition":"The count of number of Catheters used for infusion.","longName":"SUPPPR_QVAL_PRCATHDEV_CT","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F2F5B5F7-C7D2-66BD-E053-731AD00A1604","latestVersionIndicator":"Yes","beginDate":"2023-01-23","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-01-23","modifiedBy":"ZHWENDY","dateModified":"2023-08-21","changeNote":null,"administrativeNotes":"1/23/2023-created CDE for PBTC-CADSR0001919-MM","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12432581","version":"1","preferredName":"Disease Response Supplemental Qualifiers Dataset Disease Response Original Result CDISC SDTM Yes No Unknown or Not Applicable Response Terminology Indicator","preferredDefinition":"An indicator of disease response results based on assessment.","longName":"SUPPRS_RSORRES_RECURRENT_IND","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F2FA6C98-9628-3DBC-E053-731AD00A904E","latestVersionIndicator":"Yes","beginDate":"2023-01-23","endDate":null,"createdBy":"LISU","dateCreated":"2023-01-23","modifiedBy":"ZHWENDY","dateModified":"2023-08-21","changeNote":null,"administrativeNotes":"01/23/2023: created for PBTC study as study specific CDISC CDE. - SL","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12532005","version":"1","preferredName":"Procedure Supplemental Qualifiers Dataset Catheter Device Revision Post Initial Placement Yes No Indicator","preferredDefinition":"A Yes/No indicator that indicates if the catheter revision was done post-initial placement.","longName":"SUPPPR_QVAL_PRCATHREV_IND","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F3D4610C-6A7C-5FBA-E053-731AD00A246D","latestVersionIndicator":"Yes","beginDate":"2023-02-03","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-02-03","modifiedBy":"ZHWENDY","dateModified":"2023-08-21","changeNote":null,"administrativeNotes":"02/03/2023- CADSR0001919-created CDE  MM","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"12532006","version":"1","preferredName":"Procedure Supplemental Qualifiers Dataset Catheter Device Revision Post Initial Placement Specify Text","preferredDefinition":"The free text field that describes the catheter revision done post-initial placement.","longName":"SUPPPR_QVAL_PRCATHREV_SPEC","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F3D4B2FA-F832-6CD0-E053-731AD00A0A96","latestVersionIndicator":"Yes","beginDate":"2023-02-03","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-02-03","modifiedBy":"ZHWENDY","dateModified":"2023-09-08","changeNote":null,"administrativeNotes":"02/03/2023- CADSR0001919-created CDE  MM","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13230544","version":"1","preferredName":"Patient Observation Or Other Observed Change Occurrence Specify Text","preferredDefinition":"The free text field to specify patient observation or other observed changes.","longName":"PT_OTH_OBS_CHG_SPE","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F77F6FF5-24F3-1496-E053-731AD00A7A91","latestVersionIndicator":"Yes","beginDate":"2023-03-22","endDate":null,"createdBy":"ZHWENDY","dateCreated":"2023-03-22","modifiedBy":"ZHWENDY","dateModified":"2023-06-02","changeNote":null,"administrativeNotes":"6/2/2023: reviewed and released per the metric report.wz","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13230547","version":"1","preferredName":"Patient Care Impact Laboratory Test Result Occurrence Indicator","preferredDefinition":"The indicator of whether or not patient care was impacted by laboratory test result.","longName":"PT_CARE_IMPACT_IND","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F77FA7DD-7AED-0708-E053-731AD00A9EDD","latestVersionIndicator":"Yes","beginDate":"2023-03-22","endDate":null,"createdBy":"ZHWENDY","dateCreated":"2023-03-22","modifiedBy":"ZHWENDY","dateModified":"2023-06-02","changeNote":null,"administrativeNotes":"6/2/2023: reviewed and released per the metric report.wz","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13230548","version":"1","preferredName":"Diagnosis Change Occurrence Indicator","preferredDefinition":"The indicator of whether or not there were a change in diagnosis.","longName":"DX_CHG_IND","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F77FB46F-3A03-0897-E053-731AD00A5A22","latestVersionIndicator":"Yes","beginDate":"2023-03-22","endDate":null,"createdBy":"ZHWENDY","dateCreated":"2023-03-22","modifiedBy":"ZHWENDY","dateModified":"2023-06-02","changeNote":null,"administrativeNotes":"6/2/2023: reviewed and released per the metric report.wz","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13230552","version":"1","preferredName":"Therapeutic Procedure Change Indicator","preferredDefinition":"The indicator of whether or not there was a change in treatment.","longName":"TX_CHG_IND","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F77FBDB2-8D5C-099E-E053-731AD00AB24E","latestVersionIndicator":"Yes","beginDate":"2023-03-22","endDate":null,"createdBy":"ZHWENDY","dateCreated":"2023-03-22","modifiedBy":"ZHWENDY","dateModified":"2023-06-02","changeNote":null,"administrativeNotes":"6/2/2023: reviewed and released per the metric report.wz","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13230805","version":"1","preferredName":"Patient Observation Change Occurrence Indicator","preferredDefinition":"The indicator of whether or not there was a change in patient observation.","longName":"PT_OBS_CHG_IND","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F77FC826-30BE-0B17-E053-731AD00A6578","latestVersionIndicator":"Yes","beginDate":"2023-03-22","endDate":null,"createdBy":"ZHWENDY","dateCreated":"2023-03-22","modifiedBy":"ZHWENDY","dateModified":"2023-06-02","changeNote":null,"administrativeNotes":"6/2/2023: reviewed and released per the metric report.wz","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13230806","version":"1","preferredName":"Other Observed Change Occurrence Indicator","preferredDefinition":"The indicator of whether or not there was any other observed change.","longName":"OTH_OBS_CHG_IND","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F77FFCCD-31B2-1557-E053-731AD00AC670","latestVersionIndicator":"Yes","beginDate":"2023-03-22","endDate":null,"createdBy":"ZHWENDY","dateCreated":"2023-03-22","modifiedBy":"ZHWENDY","dateModified":"2023-06-02","changeNote":null,"administrativeNotes":"6/2/2023: reviewed and released per the metric report.wz","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"13569882","version":"1","preferredName":"Cerebrospinal Fluid Ventricular Collection Procedure Site Type","preferredDefinition":"A description of the procedure site for the cerebrospinal fluid ventricular collection.","longName":"CSF_COLL_PRCD_SITE_TY","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FB81E4DE-711B-3311-E053-731AD00AA2BF","latestVersionIndicator":"Yes","beginDate":"2023-05-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-12","modifiedBy":"KUMMEROA","dateModified":"2023-09-12","changeNote":null,"administrativeNotes":"2023.9.12 Released per metrics report. ak 2023.5.12 Created per ticket request CADSR0002408. ak","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14428735","version":"1","preferredName":"Procedures Supplemental Qualifiers Dataset Tumor Debulking Fulfill Protocol Defined Target Yes No Indicator","preferredDefinition":"The indicator weather or not the tumor debulked by the surgery meet study protocol defined target.","longName":"SUPPPR_QVAL_DEBLKSUC","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"03839C3E-8CBC-7B62-E063-731AD00ABE95","latestVersionIndicator":"Yes","beginDate":"2023-08-22","endDate":null,"createdBy":"LISU","dateCreated":"2023-08-22","modifiedBy":"MMADDINENI","dateModified":"2023-09-07","changeNote":null,"administrativeNotes":"09/07/2023-Reviewed and released-MM08/22/2023: created for PBTC CADSR0002767. -SL","unresolvedIssues":null,"deletedIndicator":"No"},{"publicId":"14428747","version":"1","preferredName":"Procedures Supplemental Qualifiers Dataset Catheter Placement Device Count","preferredDefinition":"Information on number of catheters placed.","longName":"SUPPPR_QVAL_CATHNUM","contextName":"PBTC","contextVersion":"1","dataElementConceptPublicId":"4232093","dataElementConceptVersion":"1","valueDomainPublicId":"4232128","valueDomainVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"03846E02-60F3-1C22-E063-731AD00AB278","latestVersionIndicator":"Yes","beginDate":"2023-08-22","endDate":null,"createdBy":"LISU","dateCreated":"2023-08-22","modifiedBy":"MMADDINENI","dateModified":"2023-09-07","changeNote":null,"administrativeNotes":"09/07/2023-Reviewed and released-MM08/22/2023: created for PBTC CADSR0002767. -SL","unresolvedIssues":null,"deletedIndicator":"No"}]}